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ABSTRACT 
Depressive disorders are a major public health concern worldwide due to 
their pervasiveness, often chronic or recurrent course and serious adverse 
outcomes. These include psychosocial disability, reduced quality of life, 
physical health problems and increased mortality. This study examined 
prevalence, predictors and different adverse outcomes of depressive 
disorders (major depressive disorder and dysthymia) in a general population 
setting. Specifically, the study aimed to establish the prevalence of depressive 
disorders in Finland in 2011 and assess possible changes over the past 
decade; to examine risk factors for new-onset depressive disorders; to 
investigate the long-term prognosis of depressive disorders and its 
determinants; and to assess excess mortality associated with depressive, 
anxiety and alcohol use disorders. A large longitudinal study of the Finnish 
population, consisting of the Health 2000 and Health 2011 Surveys, was used 
to investigate these questions. The survey data was complemented with data 
from the Care Register for Health Care and the Finnish Causes of Death 
Statistics. 
 
The results show that one in 10 adults in Finland suffered from a depressive 
disorder in 2011, and the prevalence increased from 2000 to 2011, 
particularly among women. Methods to account for non-participation also 
showed that the non-participation of people with depressive disorders in 
population studies significantly biases prevalence estimates. People who 
were younger, had a history of multiple childhood adversities, lower trust 
axis of social capital, or an anxiety disorder or subclinical depressive 
symptoms at baseline, had a higher risk of developing depressive disorders. 
In addition, having three or more physical diseases was a risk factor for 
dysthymia.  Among people with depressive disorders at baseline, 34-43% still 
had some depressive, anxiety or alcohol use disorder after 11 years, and 48-
61% had clinically significant depressive symptoms. Unmarried people and 
those with more severe initial symptoms had a higher risk of persistent 
course. People with depressive disorders had a twofold mortality risk, 
whereas the risk was 1.7-fold in alcohol use disorders and was not increased 
in anxiety disorders, when adjusted for other risk factors. 
 
This study confirms that depression is an increasing public health concern in 
Finland, and that depressive disorders have serious long-term consequences. 
To reduce the burden of depressive disorders, it is of key importance to 
develop primary prevention efforts and measures to reduce the negative 
health and social consequences of depression. 
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TIIVISTELMÄ 
Masennushäiriöt ovat merkittävä kansanterveydellinen ongelma 
maailmanlaajuisesti. Ne ovat yleisiä, usein pitkäkestoisia ja niillä on suuri 
taipumus uusia. Niihin liittyy vakavia kielteisiä seurauksia, kuten 
psykososiaalista haittaa, heikentynyttä elämänlaatua, fyysisen terveyden 
ongelmia ja lisääntynyttä kuolleisuutta. Tässä tutkimuksessa selvitettiin 
masennushäiriöiden (masennustilan sekä pitkäkestoisen masennuksen) 
esiintyvyyttä, riskitekijöitä ja erilaisia kielteisiä seurauksia pitkittäisessä 
väestötutkimuksessa. Tutkimuksen tavoitteina oli selvittää 
masennushäiriöiden esiintyvyys Suomessa vuonna 2011 ja arvioida 
esiintyvyyden mahdollisia muutoksia viime vuosikymmenen aikana, tutkia 
masennushäiriöiden ilmaantuvuuden riskitekijöitä, selvittää 
masennushäiriöiden pitkän aikavälin ennustetta ja siihen vaikuttavia 
tekijöitä sekä arvioida masennus-, ahdistus- ja alkoholihäiriöihin liittyvää 
ylikuolleisuutta. Tutkimusaineistona käytettiin Terveys 2000 - ja Terveys 
2011 –tutkimuksia, jotka muodostavat yhdessä pitkittäisen 
väestötutkimuksen. Väestötutkimuksen tietoja täydennettiin 
hoitoilmoitusrekisterin ja kuolemansyyrekisterin tiedoilla.  
 
Tulokset osoittavat, että yhdellä kymmenestä suomalaisesta aikuisesta oli 
masennushäiriö vuonna 2011. Masennushäiriöiden esiintyvyys lisääntyi 
vuosien 2000 ja 2011 välillä erityisesti naisilla. Väestötutkimusten 
perusteella tehdyt arviot masennushäiriöiden esiintyvyydestä voivat olla 
todellista pienempiä, koska niistä kärsivät henkilöt osallistuvat 
väestötutkimuksiin muita harvemmin. Riskitekijöitä uusien 
masennushäiriöiden ilmaantumiselle olivat nuori ikä, useat lapsuuden 
vastoinkäymiset, ahdistuneisuushäiriö, lievät masennuksen oireet jo 
tutkimuksen alussa sekä sosiaalisen pääoman ulottuvuuksista heikko kyky 
tuntea luottamusta. Niistä seurantatutkimuksen henkilöistä, joilla oli 
tutkimuksen alussa masennushäiriö, 34‒43 %:lla oli todettavissa masennus-, 
ahdistus- tai alkoholihäiriö yhdentoista vuoden kuluttua 
seurantatutkimuksessa, ja 48‒61 %:lla oli kliinisesti merkittäviä 
masennusoireita. Riski häiriön pitkittymiselle oli suurempi niillä, joilla oli 
muita vaikeampia oireita vuonna 2000, sekä niillä, jotka eivät olleet 
naimisissa tai avoliitossa. Masennushäiriöihin liittyi kaksinkertainen 
kuolleisuusriski, alkoholihäiriöissä riski oli 1.7-kertainen, kun taas 
ahdistushäiriöissä riski ei ollut suurentunut. 
 
Tämä tutkimus vahvistaa, että masennushäiriöt ovat kasvava 
kansanterveysongelma Suomessa ja niillä on vakavia pitkäaikaisia 
seurauksia. On erittäin tärkeää kehittää sekä ennaltaehkäisyä että 
6 
toimenpiteitä, joilla vähennetään masennushäiriöiden kielteisiä 
terveydellisiä ja sosiaalisia seurauksia. 
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1 INTRODUCTION 
Depression can be used to describe everyday feelings of sadness. However, it 
also refers to a psychiatric disorder whose key feature is a sad or depressed 
mood, accompanied by other distinct symptoms, including loss of interest, 
fatigue, memory problems, insomnia and recurrent thoughts of death. 
Typically, the disorder causes suffering and renders the person affected 
partly or fully unable to carry on with everyday life. 
 
Every year, approximately one in 20 people suffers from major depressive 
disorder (MDD) (Ferrari et al., 2013c). However, this rough estimate 
depends on how the exact criteria of the disorder are defined, how it is 
measured, and in which population, country and continent the study is 
carried out (Kessler and Bromet, 2013). The annual prevalence of dysthymia 
(another common depressive disorder with typically a more chronic course 
than MDD) is much lower, estimated at 1-2% (Charlson et al., 2013, Gureje, 
2011, Waraich et al., 2004). From 9-16% of the population may have a 
depressive disorder severe enough to warrant specialised medical care over 
the course of their lifetime (Pedersen et al., 2014) and many more will suffer 
from a less severe form. Increased awareness of depression in society and 
increased use of antidepressants has led many to believe that the prevalence 
of depression has increased, but there have been no indications of this in 
previous population studies (Ferrari et al., 2013c, Patten et al., 2015a). 
 
Depression is more common among women, younger people, unmarried or 
divorced individuals, and those in a socially disadvantaged position (Kessler 
and Bromet, 2013). It is not clear, however, whether the association between 
these factors and depression necessarily implies causation. Some factors may 
increase the risk of developing depression, while others decrease the 
likelihood of recovery. 
 
The age of onset of depression is typically in the early 20s, but there is wide 
variation (Kessler and Bromet, 2013). On average, an illness episode lasts a 
few months (Eaton et al., 2008b, Kessler et al., 2003, Spijker et al., 2002), 
but a chronic or recurrent course is regrettably common (Eaton et al., 2008b, 
Spijker et al., 2002). Depression may negatively impact educational 
attainment, marital relations, employment, parental functioning, as well as 
general health status and mortality risk (Kessler and Bromet, 2013). The risk 
of suicide increases as much as 20-fold compared to people without 
depression, and 4-7% of depressed individuals die by suicide (Holmstrand et 
al., 2015, Isometsä, 2014, Nordentoft et al., 2011). 
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The aim of this study is to examine prevalence, predictors and different 
adverse outcomes of depressive disorders in a general population setting. 
The study is based on two large health examination surveys of the Finnish 
population, the Health 2000 study and its follow-up study, the Health 2011 
Survey. In addition, register data on hospitalisations and mortality is utilised.  
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2 REVIEW OF THE LITERATURE 
2.1 DEFINITION OF DEPRESSIVE DISORDERS  
Depressive disorders refer to conditions that are characterised by sad or 
depressed mood and also entail other symptoms, such as inability to 
experience pleasure, feelings of guilt, thoughts of death, cognitive symptoms 
(such as diminished ability to think or concentrate) and physical changes 
(such as insomnia and loss of appetite). These disorders cause emotional and 
physical suffering, and often lead to reduction in functional capacity and the 
ability to work.  
 
The pathophysiology, or mechanism of how depressive disorders develop in 
the human body, is not clear. This is why the diagnostic criteria rely on 
describing a collection of symptoms considered essential and characteristic 
of the disorder. Currently, two diagnostic systems are in place: the 
International Classification of Diseases, 10th revision (ICD-10), and the 
Diagnostic and Statistical Manual, fourth and fifth revisions (DSM-IV and 
DSM-5). The ICD-10 is used by health care systems in many countries, 
including Finland, whereas the DSM-IV and DSM-5 are frequently used in 
research. Both criteria are presented here. 
2.1.1 ICD-10 
According to the ICD-10 Classification of Mental and Behavioural Disorders 
(WHO, 1993), a depressive episode (code F32) is a condition that lasts a 
minimum of two weeks and is characterised by at least two of three core 
symptoms: depressed mood that is present for most of the day and almost 
every day; loss of interest in activities that the person normally enjoys; and 
fatigue or decreased energy. In addition, one or more of the following 
symptoms must also be present, so that there are a minimum of four: loss of 
confidence and self-esteem; excessive and inappropriate guilt; recurrent 
thoughts of death, suicide or suicidal behaviour; diminished ability to think 
or concentrate; agitation or retardation; sleep disturbance; change in 
appetite and weight change. In addition to these symptom criteria, 
hypomanic or manic episodes should be excluded, as well as the symptoms 
attributable to psychoactive substance use or organic mental disorder. 
 
Depressive episodes are further classified into mild (4-5 symptoms), 
moderate (6-7 symptoms) or severe (8-9 symptoms). If the person has had 
prior depressive episodes and recovered for a minimum of 2 months between 
episodes, the disorder is called “Recurrent depressive disorder” (F33).  
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Dysthymia (F34.1) is a condition of depressed mood either constantly or 
recurrently for a minimum of two years, in which periods of normal mood do 
not last for longer than a few weeks. Few or none of the episodes are severe 
enough to meet criteria for recurrent mild depressive disorder. Three of the 
following symptoms should be present during some of the periods of 
depression: reduction in energy or activity; insomnia; loss of self-confidence; 
difficulty concentrating; tearfulness; loss of interest in sex and other 
pleasurable activities; feelings of hopelessness; perceived inability to cope 
with everyday responsibilities; pessimistic attitude toward the future or 
brooding over the past; withdrawal from social activities; and being less 
talkative than normal. The onset of dysthymia may be early (adolescence to 
late 20s) or late, often following a depressive episode. 
 
The ICD-10 also presents criteria for “Recurrent brief depressive disorder” 
(F38.10), in which recurrent episodes of equal intensity but shorter duration 
than depressive episode occur. 
2.1.2 DSM-IV 
The DSM-IV criteria for major depressive disorder (MDD) (code 296.xx) 
include minimum duration of two weeks, presence of either depressed mood 
or anhedonia most of the day and nearly every day, and other symptoms of 
the following, for a minimum of five: significant change in appetite or weight; 
insomnia or hypersomnia; psychomotor retardation or agitation observable 
to others; fatigue or loss of energy; excessive or inappropriate guilt or 
worthlessness; diminished ability to think or concentrate; and recurrent 
thoughts of death or suicide. The disorder is classified into mild, moderate, 
severe or with psychotic features. 
 
In addition to symptom and duration criteria, DSM-IV criteria require that 
the condition cause clinically significant distress or impairment in social, 
occupational or other areas. Exclusion criteria of mania, hypomania, 
substance use and somatic conditions are similar to ICD-10. In addition, the 
DSM-IV does not establish a diagnosis of MDD if symptoms are related to 
the loss of a loved one within the past two months, unless the symptoms 
include psychomotor retardation, excessive or inappropriate guilt, 
suicidality, psychotic symptoms, or are associated with a marked decrease in 
functional capacity.  
 
Dysthymia (300.4) is described as a disorder where the mood is depressed 
for most of the day more than half of the time for two years or more, and two 
or more of the following symptoms are present: change in appetite; insomnia 
or sleeping too much; low energy; low self-esteem, poor concentration; and 
hopelessness. The symptoms should cause significant impairment in social, 
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work or other important areas. Symptom-free periods must be no longer 
than two months. 
2.1.3 DSM-5 
There were no changes to core symptoms or duration criteria for MDD 
between DSM-IV and DSM-5. A new specifier “with mixed features” was 
introduced to describe a depressive episode with a maximum of three manic 
symptoms. The most notable change was the omission of the bereavement 
exclusion. This was due to the fact that the time limit was considered 
arbitrary and not in line with actual duration of grieving, and because 
bereavement-related MDD does not differ from non-bereavement-related 
MDD in terms of risk factors, previous history of depression, and course or 
response to treatment (Kendler et al., 2008, Uher et al., 2014). In the DSM-
5, bereavement is likened to other stressors that commonly influence the 
onset and course of MDD. In one study of individuals who experienced a 
brief major depressive episode (less than two months), 38% reported the 
disorder to be bereavement-related (McCabe and Christopher, 2015), with 
certain distinct differences to the non-bereavement related episodes, such as 
less suicidality and worthlessness. 
 
In the DSM-5, dysthymia was reconceptualised as “persistent depressive 
disorder” (PDD) (300.4). This category includes both chronic major 
depressive disorder and former dysthymia. The change was made because no 
significant differences between these two conditions had been established, 
whereas significant differences appear to exist between chronic and non-
chronic depression. Some 29% of individuals with lifetime depression are 
estimated to suffer from persistent depressive disorder (Murphy and Byrne, 
2012). 
 
“Premenstrual dysphoric disorder” (625.4) was moved from an appendix to 
the main category of depressive disorders. “Disruptive mood dysregulation 
disorder” (269.99) for children up to 18 years was also added to the category. 
 
The changes to the diagnostic categories of depressive disorders in the DSM-
5 may result in changes in prevalence (Uher et al., 2014). Guidance on 
whether PDD and MDD can be diagnosed at the same time is contradictory, 
but according to PDD criteria: “If the symptom criteria are sufficient for a 
diagnosis of a major depressive episode at any time during this period, then 
the diagnosis of major depression should be noted, but it is coded not as a 
separate diagnosis but rather as a specifier with the diagnosis of persistent 
depressive disorder.” Therefore, it is possible that the prevalence of MDD will 
decrease, as chronic cases will be diagnosed as PDD. On the other hand, the 
omission of the bereavement exclusion may result in an increase in the 
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prevalence of MDD, given the large proportion of people who attributed a 
depressive episode to bereavement (McCabe and Christopher, 2015). 
2.1.4 MAIN DIFFERENCES BETWEEN THE DIAGNOSTIC SYSTEMS 
The main differences in diagnostic criteria for MDD between the ICD-10 and 
the DSM (IV and 5) systems are: 1) the different number of symptoms 
required (four in ICD-10 and five in DSM); 2) different number of core 
symptoms (three in ICD-10 and two in DSM); and 3) the DSM criterion of 
“significant distress or functional impairment,” which the ICD-10 does not 
consider (Table 1).  
 
In the case of dysthymia, the differences are: 1) minimum number of 
symptoms (four in ICD-10 and three in DSM); and 2) number of symptoms 
listed (12 in ICD-10 and seven in DSM). 
 
Table 1. Main differences in the diagnostic systems of depressive disorders: ICD-10, 
DSM-IV and DSM-5 
 Core symptoms Number of 
symptoms 
(total) 
Other criteria Exclusion 
 
Major depressive disorder 
ICD-10 Minimum 2 of the 
following: depressed 
mood, anhedonia, and 
decreased energy or 
fatigue 
4 - Hypomania, mania, 
symptoms 
attributable to 
psychoactive 
substance use or 
organic mental 
disorder 
DSM-IV Either depressed 
mood or anhedonia 
5 Must cause 
clinically 
significant 
distress or 
impairment 
Same as in ICD-10, 
and also if symptoms 
occur within 2 months 
of bereavement 
DSM-5 As in DSM-IV 5 As in DSM-IV Same as in ICD-10, 
no bereavement 
exclusion 
 
Dysthymia 
ICD-10 Depressed mood 
either constantly or 
recurrently for a 
minimum of two years 
4 (not 
necessarily at 
the same time) 
from a list of 12 
 Mania 
DSM-IV Depressed mood 3 from a list of 
7 
 MDD in the first two 
years, mania, 
substance induced 
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2.2 PREVALENCE OF DEPRESSIVE DISORDERS 
2.2.1 MEASUREMENT OF DEPRESSIVE DISORDERS IN POPULATION 
STUDIES 
 
There is wide variation in prevalence of depressive disorders across 
countries. This is assumed to be due to real, existing variations and to 
methodological differences in the studies. 
 
One issue is the diverse definitions of depression. Some studies include MDD 
only, whereas others measure MDE, including bipolar depression. Still others 
include dysthymia or depression not otherwise specified. Wider inclusion of 
diagnostic categories increases observed prevalence rates (Ferrari et al., 
2013c). 
 
Diagnostic instruments also matter. When symptom scales are used as a 
basis of diagnosis, measured prevalences tend to be higher than when 
structured diagnostic interviews are used (Ferrari et al., 2013c). Some studies 
have also found higher prevalences using ICD-10 instead of DSM-IV; in 
others no significant differences existed (Andrews et al., 2001, Ferrari et al., 
2013c). Differences among studies in target population, sampling and 
participation rates also contribute to inaccuracies in prevalence estimates. 
 
Finally, conceptual models of depression as well as the presentation of 
symptoms differ across cultures (Karasz, 2005, Ventevogel et al., 2013). This 
limits the applicability of psychometric instruments designed for different 
cultural contexts. To enable comparison and for practical reasons, however, 
the same standardised and validated instruments are normally used in 
epidemiological studies, irrespective of the context. 
2.2.1.1 Methods of assessing depressive disorders in population 
studies 
Population studies on psychiatric disorders require tools that are reliable, 
replicable and valid to the construct they are measuring, as well as feasibly 
applicable to thousands of persons at a reasonable cost. The latter requisite 
generally limits the time available and the type of professional who can 
administer the tool. 
 
Two methods that meet these requirements are structured interviews and 
symptom scales. Structured interviews (or schedules) are designed to assess 
the presence of a psychiatric disorder dichotomously – the disorder either is 
or is not present. They were developed to enable psychiatric assessment in 
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population surveys using lay interviewer-administered tools (Brugha et al., 
1999). There are two types of structured interviews: semi-structured and 
fully structured interviews. A semi-structured interview is performed by a 
mental health professional, usually a psychiatrist or psychologist, and 
resembles a clinical examination, where the questions have a standard 
wording, but probing and further questions are flexible. In a fully structured 
interview, a trained lay interviewer asks the questions and clarifying 
questions or further details exactly as has been written, and codes answers 
according to instructions. The usefulness of a fully structured interview 
depends greatly on the exact wording and how understandable it is to the 
participants. In practice, due to human resource costs, population surveys 
always use fully structured interviews. 
 
The most frequently used structured interview is the Composite 
International Diagnostic Interview (CIDI) in its various forms (see Chapter 
4.2 for a more detailed description of this instrument). The most relevant 
structured interviews are listed in Table 2.  
 
Table 2. Structured diagnostic interviews to assess depressive disorders in 
epidemiological studies, ordered by decade of first publication of the instrument 
Structured diagnostic interviews (schedules) used to establish diagnosis of 
depression in epidemiological studies 
Fully / 
Semi-
structured 
PSE Present State Examination 1960s Semi 
CIS (-R) Clinical Interview Schedule (Revised) 1970s Fully 
SADS Schedule for Affective Disorders and Schizophrenia 1970s Semi 
DIS Diagnostic Interview Schedule 1980s Fully 
DPAX Depression and Anxiety Schedule 1980s Fully 
ISPI Iowa Structured Psychiatric Interview 1980s Fully 
MINI Mini-International Neuropsychiatric Interview 1990s Fully 
SCAN Schedules for Clinical Assessment in Neuropsychiatry 
(development of PSE) 
1990s Semi 
CIDI Composite International Diagnostic Interview (UM-CIDI, 
WMH-CIDI, M-CIDI) (development of DIS) 
1990s Fully 
PRIME-
MD 
Primary Care Evaluation of Mental Disorders 1990s Semi 
SCID Structured Clinical Interview for DSM (III-R, IV and 5) 
(development of SADS) 
1990s Semi 
 
 
Symptom scales are designed to measure symptoms of a disorder in a 
dimensional scale. Sometimes these scales are used to identify people with 
possible depressive disorder by establishing a cut-off point, above which the 
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disorder is possible or probable. They are also used in clinical practice to 
monitor levels of symptoms, which is their original intended use. The most 
relevant self-reported depressive symptom scales are listed in Table 3.  
 
Table 3. Symptom scales to assess depressive symptoms, ordered by decade of first 
publication of the instrument 
Symptom scales used to assess level of symptoms and establish possible diagnosis of 
depression 
HSCL Hopkins Symptom Checklist 1950s 
BDI Beck Depression Inventory 1960s 
Zung Zung Depression Scale 1960s 
CES-D The Center for Epidemiologic Studies Depression Scale 1970s 
HADS Hospital Anxiety and Depression Scale 1980s 
PERI Psychiatric Epidemiological Research Instrument 1980s 
BDI-II Beck Depression Inventory II 1990s 
SCL-90 Symptom Checklist 90 items (development of HSCL) 1990s 
DEPS The Depression Scale 1990s 
PHQ-G Personal Health Questionnaire 1990s 
PHQ Patient Health Questionnaire 2000s 
 
 
The advantage of symptom scales over structured interviews is the shorter 
time needed, and the fact that they are self-administered. However, their 
diagnostic validity is limited (Pettersson et al., 2015). In this literature 
review, studies using valid diagnostic procedures based on structured 
interviews are prioritised.  
2.2.1.2 Methodological challenges in prevalence studies 
2.2.1.2.1 Non-participation of people with mental disorders 
When prevalence of mental disorders is assessed through population surveys, 
participation in these surveys may influence estimates of prevalence. Many 
studies indicate that people with psychiatric disorders have a lower 
likelihood of participating in population studies (Eaton et al., 1992, Suvisaari 
et al., 2009). Different types of psychiatric disorders have been found to 
contribute to non-participation (Haapea et al., 2008). Disorder severity, 
however, may increase risk of non-participation in both psychotic and non-
psychotic disorders (Haapea et al., 2007, Lamers et al., 2012). Conversely, 
studies in the Netherlands have found that non-participation was associated 
with correlates of mental disorders, such as low education, younger age and 
unemployment, but not the disorders themselves (de Graaf et al., 2000, de 
Graaf et al., 2013). These results have not been replicated in other studies. 
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Therefore, non-participation of people with psychiatric disorders may bias 
prevalence estimates. It is thus likely that true prevalences are higher than 
those estimated based on population surveys that do not correct for non-
participation (Haapea et al., 2008).  
 
2.2.1.2.2 Lifetime prevalence estimates 
Doubts on the accuracy of lifetime prevalence estimates in population 
surveys have been raised for two main reasons:  the high ratio of period and 
lifetime prevalence rates; and the curvilinear association of lifetime 
prevalence estimates with age (Parker, 1987). In the first case, a low ratio of 
period to lifetime prevalence would be expected in the case of episodic 
disorders, such as depression. However, period prevalences of 50-60% of 
lifetime prevalence are often observed (Moffitt et al., 2010, Parker, 1987). In 
the second case, one would assume an increasing prevalence of lifetime 
disorders with age. However, the lifetime prevalence of depression peaks at 
mid-life and then decreases.  
 
Both observations are explained by recall bias, which is the systematic 
inaccuracy of reporting events that occurred in the past. The influence of 
recall bias on assessments of lifetime prevalence of mental disorders has 
been ascertained in several studies (Kruijshaar et al., 2005, Moffitt et al., 
2010, Patten et al., 2012, Takayanagi et al., 2014). When comparing 
prospective to retrospective study settings, the rate of lifetime mental 
disorders was double in the prospective compared to retrospective 
assessment (Moffitt et al., 2010). In the case of MDD, the increase is almost 
threefold: the lifetime prevalence evaluated retrospectively was 4.5%, 
whereas cumulative evaluation from several waves of a prospective survey 
yielded a lifetime prevalence of 13.1% (Takayanagi et al., 2014). In another 
prospective study, only 40% of persons reported a past depressive episode, 
verified in a previous wave of the study, 10 years after it had occurred (Patten 
et al., 2012). Finally, when the association of declining lifetime prevalence 
with age was examined, it was explained by recall bias, and possibly 
differential mortality rates, rather than cohort effect (Patten, 2003). 
 
For these reasons, this literature review focuses on period prevalence only, 
and 12-month prevalence is presented whenever available. 
2.2.2 GLOBAL PREVALENCE OF MAJOR DEPRESSIVE DISORDER 
 
The prevalence of major depressive disorder (MDD) varies widely depending 
on the population studied and the diagnostic instrument and diagnostic 
criteria used. A recent systematic review found the lowest prevalence 
(0.05%) in Japanese males aged 65 and older in 1998, using a structured 
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clinical interview (SCID). This review found the highest prevalence (73%) 
among women aged 15 and older in post-war Afghanistan in 2005, using a 
symptom scale (HSCL-25) (Ferrari et al., 2013c). 
 
When comparing representative adult population studies, differences still 
exist between studies, countries and regions. These variations are not 
explained by country income categories: applying standardised methodology 
across 18 countries, the WHO World Mental Health Surveys, (WMHS) found 
an average 12-month prevalence of 5.5% in high-income countries and 5.9% 
in low-income countries (Bromet et al., 2011). In contrast, regional 
differences do exist, so that low prevalences are found in East and Southeast 
Asia and Sub-Saharan Africa, whereas higher prevalences are found in North 
and South America, North Africa and some European countries (Bromet et 
al., 2011, Ferrari et al., 2013c, Steel et al., 2014). 
 
Some variations are related to the methodological issues discussed in 
Chapter 2.1.1. But it is likely true that differences between countries do also 
exist. The WMHS used the same structured interview and similar sampling 
procedures in all participating countries, and still found fivefold differences 
in 12-month prevalence of MDE, varying from 2.2% in Japan to 10.4% in 
Brazil (Bromet et al., 2011). Previously, it was thought that the differences 
might be due to different reporting thresholds. But analyses of the WMHS 
data demonstrate increasing disability with increasing prevalence, pointing 
at a true difference in prevalence rather than differences in interpretation or 
measurement (Kessler and Bromet, 2013). 
 
Recent high-quality reviews of epidemiological literature of MDD have 
established a global point-prevalence (current or past month) of 4.7% and a 
“pooled period prevalence of mood disorder” (point or 12-month) of 5.4% 
(Ferrari et al., 2013c, Steel et al., 2014). Earlier systematic reviews and meta-
analyses have placed the average 12-month prevalence in the range of 4.1% to 
6.9% (Eaton et al., 2008a, Waraich et al., 2004, Wittchen et al., 2011). 
Several nationally representative studies have found annual prevalences of 
3.9% to 6.8% (Table 4). It can therefore be concluded that the global 12-
month prevalence of MDD is approximately 5%, but that significant 
variations exist between countries and regions.  
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Table 4. Prevalence of depressive disorders in different general population studies 
 
Publication 
 
Study setting 
 
Instrument 
used 
12-month 
prevalence 
of MDD 
Bijl et al., 1998. Prevalence of 
psychiatric disorder in the 
general population: 
results of the Netherlands 
Mental Health Survey 
and Incidence Study 
(NEMESIS) (Bijl et al., 1998) 
Netherlands Mental 
Health Survey 
and Incidence Study-
(NEMESIS), 
representative of the 
Dutch general population 
aged 18-64 
CIDI 5.8% 
Murphy et al., 2000. A 40-year 
Perspective on the Prevalence 
of Depression (Murphy et al., 
2000) 
Stirling County Study, 
longitudinal general 
population study in 
Canada (general 
population aged 18 and 
older; in 1952 heads of 
households only) 
DPAX 1 and 2, 
DIS 
5.3% in 1952 
and 1970, 
2.9-5.7% in 
1990 
depending on 
instrument 
Andrews et al., 2001. 
Prevalence, comorbidity, 
disability and service utilisation. 
(Andrews et al., 2001) 
Australian National 
Mental Health Survey, 
representative population 
study of persons 18 years 
and older  
CIDI 2.1 6.7% (ICD-
10), 6.3% 
(DSM-IV) 
Kessler et al., 2003. The 
Epidemiology of Major 
Depressive Disorder. 
(Kessler et al., 2003) 
National Comorbidity 
Survey Replication (NCS-
R), representative 
population survey of 
household residents aged 
18 and older in the US 
WHO-CIDI 6.6% 
Hasin et al. 2005. Epidemiology 
of Major Depressive Disorder 
(Hasin et al., 2005) 
National Epidemiologic 
Survey on Alcoholism 
and Related Conditions, 
nationally representative 
population survey of 
household residents aged 
18 and older in the US 
Alcohol Use 
Disorder and 
Associated 
Disabilities 
Interview 
Schedule–
DSM-IV 
Version 
(AUDADIS-IV) 
5.3% 
de Graaf et al., 2012. 
Prevalence of mental disorders 
and trends from 1996 to 2009. 
Results from the Netherlands 
Mental Health Survey 
and Incidence Study-2 
(de Graaf et al., 2012) 
Netherlands Mental 
Health Survey and 
Incidence Study 2 
(NEMESIS-2), 
representative of the 
Dutch general population 
aged 18-64 
CIDI 3.0 5.2% 
Patten et al. 2015 Descriptive 
Epidemiology of Major 
Depressive Disorder in Canada 
in 2012 
(Patten et al., 2015b) 
Canadian Community 
Health Study—Mental 
Health (CCHS-MH), 
nationally representative 
study of persons 15 years 
and over 
WHO-CIDI 3.9% 
Jacobi et al., 2015. Twelve-
months prevalence of mental 
disorders in the German Health 
Interview and Examination 
Survey for Adults – Mental 
Health Module (DEGS1-MH) 
German Health Interview 
and Examination Survey 
for Adults 
Mental Health Module 
(DEGS1-MH), nationally 
representative study of 
DEGS-CIDI 6.8% 
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(Jacobi et al., 2015) the population aged 18-
79 
 
Reviews and cross-national studies 
Andrade et al., 2003. The 
epidemiology of major 
depressive episodes: results 
from the International 
Consortium of Psychiatric 
Epidemiology (ICPE) Surveys. 
(Andrade et al., 2003) 
Cross-national study of 
general populations with 
10 low- to high-income 
countries included 
WHO-CIDI, 
University of 
Michigan-CIDI 
and Munich-CIDI 
Variation 
from 1.2% 
in Japan to 
10.0% in 
the US 
(MDE, not 
MDD) 
Waraich et al., 2004. 
Prevalence and Incidence 
Studies of Mood Disorders: A 
Systematic Review of the 
Literature.  
(Waraich et al., 2004) 
Systematic review of 
general population 
studies 
15 studies using 
standardised or 
clinical diagnostic 
tools were 
included 
Pooled 
prevalence 
4.1% 
Wittchen and Jacobi, 2005. Size 
and burden of mental disorders 
in Europe—a critical review and 
appraisal of 27 studies. 
(Wittchen and Jacobi, 2005) 
Review of 27 studies in 
16 European countries 
Varying, eg. CIDI, 
GHQ 
Median 
prevalence 
6.9%, 
variance 
3.1-10.1% 
(MDE) 
Wittchen et al., 2011. The size 
and burden of mental disorders 
and other disorders of the brain 
in Europe 2010.  
(Wittchen et al., 2011) 
Systematic literature 
reviews, re-analyses of 
existing data sets, 
national surveys and 
expert consultations 
25 community 
studies on 
depression were 
included 
5.7% from 
studies; 
6.9% when 
taking into 
account 
expert 
estimates 
Bromet et al. 2011. Cross-
national epidemiology of DSM-
IV major depressive episode  
(Bromet et al., 2011) 
World Mental Health 
Surveys, 18 countries 
with nationally 
representative adult 
samples 
WHO-CIDI Average 
prevalence 
5.5% in 
high-
income and 
5.9% in 
low-income 
countries, 
variation 
from 2.2% 
to 10.4% 
Ferrari et al, 2013. Global 
variation in the prevalence and 
incidence of major depressive 
disorder: a systematic review of 
the epidemiological literature 
(Ferrari et al., 2013c) 
Systematic review and 
meta-analysis of 
community prevalence 
studies 
116 studies of 
prevalence with 
varying 
methodology, 
including 
structured 
interviews and 
symptom scales 
4.7% (point 
prevalence) 
Steel et al., 2014. The global 
prevalence of common mental 
disorders: a systematic review 
and meta-analysis 1980–2013  
(Steel et al., 2014) 
 
Random-effects meta-
analysis of prevalence 
studies of all mental 
disorders, structured 
diagnostic interview 
methodology 
174 studies from 
63 countries 
published 1980-
2013 
Pooled 
period 
prevalence 
of mood 
disorder 
5.4%  
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2.2.3 PREVALENCE OF DEPRESSIVE DISORDERS IN FINLAND  
 
In Finland, there is a long tradition of extensive population health surveys 
that include instruments to measure depression. In 1978-1980, the Mini-
Finland health survey included the Present State Examination (PSE) to 
assess prevalence of mental disorders. Some 8000 individuals from the 
general population, aged 30 years and over, were sampled. The prevalence of 
“neurotic depression” was 4.6% (Lehtinen et al., 1990). 
 
In 1996, the short form of the University of Michigan CIDI (UM-CIDI) was 
used to assess depression in a random sample of adults (15-75 years, 
n=5993). The 12-month prevalence of major depressive episode was 9.3% 
(Lindeman et al., 2000). The short form of the UM-CIDI instrument, 
however, does not apply exclusions for organic or somatic conditions, nor 
does it distinguish between different types of depression. 
 
In the Health 2000 Survey, the full version of the Munich CIDI (M-CIDI) was 
used to assess prevalence in adults 30 years and over (n=8028). The 12-
month prevalence of MDD was 4.9%; dysthymia was 2.5%; and any 
depressive disorder was 6.5% (Pirkola et al., 2005b). In these figures, non-
participation was accounted for by using poststratification weights. 
 
Incidence of depression in the general population was studied in Southwest 
Finland as part of the international ODIN study. The incidence rate for all 
depressive disorders was 28.5 / 1000 per year; for first-time episodes, it was 
20.5 / 1000 (Lehtinen et al., 2005). 
 
In summary, the prevalence of depressive disorders in Finland is very close 
to the global average. 
2.2.4 PREVALENCE OF DYSTHYMIA 
 
Compared with MDD, fewer studies have investigated the prevalence of 
dysthymia. For the Global Burden of Disease 2010 study, a thorough 
systematic review found 38 studies, and established a period (combined 
current, 1-, 3-, 6- and 12-month) prevalence of 1.6% (Charlson et al., 2013). 
Prevalences in different studies ranged from 0.0% to 8.5%. Data from many 
regions was lacking, and the estimate was partly based on modelling. Other 
reviews have found annual prevalences of 2.0% (Waraich et al., 2004) and 
0.1-1.5% (Gureje, 2011). National studies have found 0.5-1.5% 12-month 
prevalence rates in the United States (Blanco et al., 2010); 0.9-2.5% in the 
Netherlands (Bijl et al., 1998, de Graaf et al., 2012); 1.1% in Australia 
(Andrews et al., 2001); and 1.7% in Germany (Jacobi et al., 2015) 
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2.2.5 THE GLOBAL BURDEN OF DEPRESSIVE DISORDERS  
 
When only mortality is assessed, the impact of mental disorders on disease 
burden is largely underestimated. Historically, this has led to mental 
disorders being neglected within different public health priorities. The World 
Development Report of 1993: Investing in Health report introduced the 
Disability Adjusted Life Year (DALY) measure that made it possible to 
quantify, for the first time, the real impact of mental disorders on public 
health (Bank, 1993). This new focus on disability in addition to mortality has 
been of key importance in placing mental disorders on the global public 
health agenda. 
 
The global burden of disease (GBD) is calculated as a function of prevalence, 
disability and deaths due to the disorder, and is expressed in DALYs. These 
are a sum of years of life lost due to premature mortality (YLL) and years 
lived with disability (YLD), a calculation that is based on the prevalence and 
disability caused by the condition. 
 
 In the GBD 2010 study, prevalence and epidemiological modelling was done 
for both MDD and dysthymia (Charlson et al., 2013, Ferrari et al., 2013a, 
Ferrari et al., 2013c). For the disability weights, lay health state descriptions 
were presented in an online survey to nearly 15.000 lay participants from 
around the world. When 0 represents full health and 1 represents death, 
disability weights were assigned as follows: mild depression 0.16; moderate 
depression 0.41; severe depression 0.66; and dysthymia 0.16. Based on 
population surveys, it was estimated that 14% of people with depressive 
disorders are asymptomatic; 59% have a mild condition; 17% moderate; and 
11% severe. 
 
Globally, mental and substance use disorders are the leading cause of years 
lived with disability (YLD), causing 21.2% of all YLDs (Global Burden of 
Disease Study 2013 Collaborators, 2015). The burden of disability due to 
MDD (measured in YLD) increased by 53% between 1990 and 2013, but the 
age-standardised disability burden increased by only 4% (Global Burden of 
Disease Study 2013 Collaborators, 2015). The burden due to dysthymia 
increased by 55% without any significant change in age-standardised rate. 
When taking into account mortality and disability, the age-standardised rate 
of DALYs due to depressive disorders did not change significantly between 
1990 and 2013 (Murray et al., 2015). MDD ranks second (after lower back 
pain) as a contributor to the burden of years lived with disability (YLD), and 
accounts for 8.1% of all YLDs. Dysthymia is the 16th contributor and 
accounts for 1.3% (Global Burden of Disease Study 2013 Collaborators, 
2015). Considering the impact of non-participation has on prevalence 
estimates, it is likely that the global burden of depression is even higher than 
currently estimated. 
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In the GBD 2010, mortality due to depressive disorders was modelled so that 
MDD was considered a risk factor for suicide (odds ratio (OR) 19.9) and 
ischeamic heart disease (OR 1.6) (Ferrari et al., 2013b). This meant that 
MDD accounted for 16 million DALYs (46%) due to suicides, and 3.8 million 
DALYs (2.9%) due to ischemic heart disease. However, these deaths were not 
included in the calculation of burden caused by depressive disorders. Had 
they been reattributed to MDD, the overall burden of MDD would have 
increased from 2.5% to 3.4% of global DALYs, ranking as the eighth instead 
of the eleventh cause (Ferrari et al., 2013b). 
 
There is substantial regional variation in the contribution of depressive 
disorders to the overall disease burden. For example, in the North African 
and Andean South American regions, depressive disorders are the third 
leading contributor to DALYs, whereas in different parts of Sub-Saharan 
Africa they are the 13th to 19th contributor, respectively, and in South Asia 
they are the 14th contributor (Ferrari et al., 2013b). However, in the burden 
of disability (YLD) category, MDD is among the three most important 
contributors in all but a few countries globally, and in all countries it ranks 
among the top 10 (Global Burden of Disease Study 2013 Collaborators, 2015). 
In Finland, depressive disorders are the 6th leading contributor to DALYs. 
2.3 PREVALENCE TRENDS OF DEPRESSIVE 
DISORDERS OVER TIME 
Through heightened awareness of depression among the general population, 
increased help-seeking and use of services, and certain topical issues (such as 
increased disability pensions due to depression), there is a widespread 
perception that depression has increased. Contrary to his perception 
however, no studies indicate this. Globally, the point prevalence of MDD has 
remained stable at 4.4% in 1990 and 2010 (Ferrari et al., 2013c). There are 
few national studies where this has been assessed, but general population 
studies from the Netherlands, Canada, US and the UK have found no 
increase in the prevalence of depressive disorders from the 1950s to 2010s 
(Brugha et al., 2004, de Graaf et al., 2012, Kessler et al., 2005, Murphy et al., 
2000, Patten et al., 2015b). During this time, however, there have been 
changes in both the diagnostic criteria and study methodologies, which 
complicates the comparison of the studies. 
2.4 RISK FACTORS FOR DEPRESSIVE DISORDERS 
Depressive disorders are multifactorial, and both genetic and environmental 
factors increase the risk of developing depression. With age, the importance 
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of environmental factors increases (Nivard et al., 2015). There is evidence of 
a genetic risk, but efforts to identify the specific loci involved have so far 
failed. It is possible that the genetic contribution is smaller than expected, or 
that the disorder represents either different symptom clusters or different 
genetic pathways to the same symptomatic manifestation (Colman and 
Ataullahjan, 2010, Flint and Kendler, 2014, Kendler et al., 2013). 
  
Environmental correlates of depressive disorders, in particular MDD, have 
been studied extensively in cross-sectional studies. However, a factor or 
characteristic may be associated with current depression via two ways: by 
being a risk factor of incidence of the disorder; or by contributing to longer 
duration and thus increasing prevalence of depression in people with that 
characteristic (Lorant et al., 2003). To understand the mechanisms of 
etiology and target preventive efforts, knowledge about the first type of 
associations would be essential. This can only be reliably assessed in 
longitudinal studies, which are more rare than cross-sectional studies. 
 
In this literature review, primarily risk factors of incidence are reviewed. 
When correlates of prevalence are discussed, this will be specifically 
mentioned. The most important risk factors are summarised in Table 5. 
2.4.1 SOCIODEMOGRAPHIC FACTORS 
2.4.1.1 Gender 
Depression is more common among women than men (Kessler and Bromet, 
2013, Seedat et al., 2009) and this is due to its higher incidence among 
women: women have an approximately 1.5 to 2-fold risk of developing 
depression compared with men (Anthony and Petronis, 1991, De Graaf et al., 
2002, Eaton et al., 2001, Eaton et al., 2008c, Klein et al., 2013, Stegenga et 
al., 2013, Wang et al., 2010a). However, the reverse is true in prepubertal 
children, and the higher risk of women is observed only from puberty (12 
years) onwards (Wesselhoeft et al., 2015). The incidence of depression in 
women peaks at 20 years of age; and after 40 years of age, the incidence is 
close to that of men (Pedersen et al., 2014). 
 
Twin studies have been used to model the risk factors of major depression in 
men and women. They suggest that the risk of major depression results from 
three pathways in both men and women: internalising symptoms; 
externalising symptoms; and psychosocial adversity. In men, losing a parent 
as a child, low self-esteem and genetic risks were more important 
explanatory variables than in women. The authors pointed out, however, that 
the pathways in both genders were similar, and that the differences are of 
less importance than the similarities (Kendler et al., 2002, 2006). In a 
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further study, the same group noted that for women, problems in caring 
relationships and interpersonal issues (such as lack of parental warmth, 
divorce, social support and marital dissatisfaction as well as neuroticism) 
were more important risk factors than for men (Kendler and Gardner, 2014). 
For men, stressful life events of financial, occupational or legal nature, as 
well as childhood sexual abuse, conduct disorder, drug abuse, and a prior 
history of depression were more important factors than for women. 
 
Notably, the World Health Survey shows that the relative risk of women to 
men increases with increasing country income (Rai et al., 2013). On the other 
hand, in the World Mental Health Survey, the difference between men and 
women decreased in the younger cohorts (Seedat et al., 2009). They also 
found gender differences to be smaller in countries and cohorts with greater 
equality between male and female roles. An exception among countries is 
China, where some studies have found no gender differences in prevalence of 
depression (Bromet et al., 2011, Lee et al., 2009). A recent meta-analysis, 
however, did show a typical pattern of female dominance in depression (Gu 
et al., 2013). 
2.4.1.2 Age 
Depression is more prevalent in younger age groups (Kessler and Bromet, 
2013). In longitudinal studies, younger age has been established as a risk 
factor for developing depression (Eaton et al., 2008c, Stegenga et al., 2013, 
Wang et al., 2010a). This association, however, is less clear, or sometimes 
even reversed, in low-income countries (Kessler and Bromet, 2013). When 
incidence of depression was examined in a register-based study in Denmark, 
it increased steeply from 10 years of age until 20 and then reduced, until 
there was another peak at 80-90 years of age (Pedersen et al., 2014). 
 
However, these findings should be interpreted with some caution, as there 
are challenges related to diagnosing depression among older persons using 
structured clinical interviews. Comparison of the CIDI, GHQ and K-10 in the 
Australian Mental Health Survey demonstrated that inconsistencies between 
the instruments rose with age (O'Connor and Parslow, 2009). It was 
interpreted that the complex questions of the CIDI may confuse older people 
and thus lead to an underestimation of mental disorders in the elderly 
(O'Connor and Parslow, 2010). 
2.4.1.3 Socioeconomic position 
There is a well-known cross-sectional association between lower 
socioeconomic position (SEP) and depressive disorders (Fryers et al., 2003, 
Lorant et al., 2003, Pulkki-Råbäck et al., 2012). A systematic review of 51 
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prevalence studies found an OR 1.8 for prevalence of depression among the 
lowest versus the highest socioeconomic group.  
 
However, the causality of the association is a subject of debate, and both 
causal pathways have evidence and a credible theory behind them. These are 
called the “causation” theory, where low SEP is a risk factor for depression, 
and the “selection” theory, where depression either prevents upward social 
mobility or causes downward movement (Dohrenwend et al., 1992). In line 
with the “causation” theory, the stress hypothesis suggests that individuals 
with high SEP have better personal resources to cope with stress, such as 
self-esteem, coping style and locus of control, and are less prone to develop 
depression because of these resources (Lorant et al., 2003). 
 
It is important to note that three central confounders of the relationship 
between SEP and depression are gender, age and physical diseases. The latter 
is often ignored in the literature (Lorant et al., 2003). 
 
A meta-analysis of five longitudinal studies found only a slightly elevated risk 
of depression in the lowest SEP group (OR 1.2), whereas the risk of prevalent 
depression and persistence of disorder were higher (OR 1.8 and 2.0, 
respectively) (Lorant et al., 2003). This was interpreted as supporting the 
“causation” theory, and in particular the “stress” theory of higher SEP as a 
protective factor, and in the event of falling ill with depression, a factor 
promoting recovery. Many individual longitudinal studies have found 
poverty to be associated only with persistence, not onset of depression 
(Skapinakis et al., 2006, Weich and Lewis, 1998), although some have found 
an association with incidence of depression (Kosidou et al., 2011). 
 
It is most likely, however, that both processes occur simultaneously and 
interact (Lorant et al., 2003). A further question, in context of the causation 
theory, is whether the influence of lower social status on adult depression 
results from lower SEP in adulthood, or whether the influence is a result of 
adversity earlier in life (Muntaner et al., 2004). Again, it is likely that lower 
SEP both during childhood and adulthood increase the risk of depression. 
 
Of the different indicators of socioeconomic status, associations have been 
found with educational status and employment status, as well as income or 
material assets (Fryers et al., 2003). The relationship with education might 
be weaker and in many cases non-existent (Andersen et al., 2009, Kosidou et 
al., 2011). The Canadian NPHS study found very differing results according 
to employment status: lower education was associated with increased risk of 
developing depression among those who worked, but lower risk among those 
who did not work (Wang et al., 2010b).  
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In addition, financial hardship, such as having to go without meals or 
heating, is associated with current depression, independently of other 
measures of SEP (Butterworth et al., 2009, Dijkstra-Kersten et al., 2015, 
Lahelma et al., 2006, Wang et al., 2010b, Weich and Lewis, 1998). However, 
the association is cross-sectional, and it is unclear whether it predicts new-
onset depression, with both positive findings (Skapinakis et al., 2006, Wang 
et al., 2010b, Weich and Lewis, 1998) and negative ones (Butterworth et al., 
2009, Dijkstra-Kersten et al., 2015) from longitudinal studies. The causality 
here may be in the other direction: people suffering from depression may be 
more likely to experience either true or perceived financial strain. 
2.4.1.4 Marital status 
Depression is more prevalent among those who are divorced, separated or 
never-married (Kessler and Bromet, 2013). In the WMHS, being married was 
associated with reduced risk of onset of depression in men, but not in women 
(Scott et al., 2010). Being separated or divorced was associated with 
increased risk in both genders. Some other studies have also found an 
increased risk of developing depression among the unmarried (Anthony and 
Petronis, 1991), or specifically, those who separated during the follow-up 
period (Lorant et al., 2007).  
 
However, many studies have not found a significant association between 
marital status and the risk of developing depression. Therefore, it may be 
that marital status influences the course of illness, or that the causal pathway 
is reversed. 
2.4.2 FAMILY HISTORY AND EARLY LIFE EXPERIENCES 
2.4.2.1 Family history  
A meta-analysis of the genetic epidemiology of depression found a 2.8-fold 
risk in first-degree relatives of people with major depression. The heritability, 
or the proportion of variation in the population explained by genetic 
variation, is estimated at 37% (Sullivan et al., 2000). 
2.4.2.2 Early life experiences 
Many factors and experiences during childhood and adolescence have been 
established as risk factors for developing depression (Kendler et al., 2002) 
(Kendler et al., 2006). The risks start accumulating from the very beginning 
of life: low birth weight, but not premature birth, is a risk factor for 
depression (Loret de Mola et al., 2014).  
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Childhood adversities – such as low parental education (Park et al., 2013, 
Ritsher et al., 2001), parental depression (Eaton et al., 2001, Klein et al., 
2013) or any parental mental disorder (Pirkola et al., 2005a, Stegenga et al., 
2013), exposure to bullying (Bowes et al., 2015, Sourander et al., 2015) and 
family discord (Pirkola et al., 2005a), or physical, emotional or sexual abuse 
(Chen et al., 2014, Stegenga et al., 2013) – are well-known risk factors for 
depression. The accumulation of several adversities increases the risk 
(Elovainio et al., 2015, Pirkola et al., 2005a). The impact of childhood 
adversity might be more apparent in women than in men (Veijola et al., 
1998). 
 
However, childhood adversities and other early life experiences are 
frequently ascertained retrospectively, and people often report them 
inconsistently. Recently, it was demonstrated that current depression and 
stress were associated with remembering childhood adversities that the 
individual had not reported in an earlier interview, and not forgetting the 
adversities previously reported, both indicating memory bias related to 
current depression (Colman et al., 2015). 
 
Finally, threatening and other stressful events during adult life increase the 
risk of incident depression (Lehtinen et al., 2005), and adult and childhood 
stressful events are also associated with each other (Kendler et al., 2002). 
When these events, such as financial problems, robbery or work problems, 
are separated into those dependent on the individual’s behaviour and those 
independent of that behaviour, both types predict depression (Kendler et al., 
2002, 2006). 
2.4.3 SOCIAL CAPITAL 
 
Social capital refers to the collective value of the social networks possessed by 
an individual. In a Finnish study, factor analysis was used to condense 
several variables indicating aspects of social capital into three dimensions: 
social support; social participation and networks; and trust and reciprocity 
(Nieminen et al., 2008). The same dimensions have also been identified in 
other studies and expert groups (Zukewich and Norris, 2005). There was a 
strong association between trust and participation dimensions and 
psychological well-being (Nieminen et al., 2010). 
 
There is extensive literature on the association between social capital and 
mental health, and in particular depression, at both the individual (De Silva 
et al., 2005, Forsman et al., 2012, Jones et al., 2014, Nyqvist et al., 2013) and 
population level (Smith and Kawachi, 2014). A summary measure of low 
social integration correlated with increased suicide risk among women in the 
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US (Tsai et al., 2015). With few exceptions, these associations have been 
established cross-sectionally. 
 
One study looked specifically at social capital and risk of depression in a 
prospective setting and found that the increased risk of depression among 
people with low social trust was explained by baseline depression (Fujiwara 
and Kawachi, 2008). The Dutch NESDA study also did not find any measure 
of social support (having a partner, network size, perceived emotional 
support) to predict new depressive episodes when controlled for personality 
features and clinical characteristics (Noteboom et al., 2015). However, other 
longitudinal studies have identified social isolation (Kaplan et al., 1987), lack 
of social support (Stegenga et al., 2013) and decreased social participation 
(Kivelä et al., 1996) to predict the onset of depression.  
2.4.4 CHRONIC SOMATIC CONDITIONS AND HEALTH BEHAVIOURS 
 
Many chronic diseases have high comorbidity with depression. Having a 
chronic physical disease predicts the onset of depression (Kaplan et al., 1987, 
Patten, 2001, Stegenga et al., 2013, Wang et al., 2010a). In addition to 
chronic diseases, traumas, such as traumatic brain injuries, also increase the 
risk of depression (Perry et al., 2016). People with chronic somatic disorders 
may also have a longer course of illness. This, together with increased 
incidence, results in a higher prevalence of depression among people with 
chronic somatic disorders (Patten, 2005). The association may be directly 
causal, as in the case of hypothyroidism, or it may be that the experience of 
living with a chronic illness contributes to developing depression. Common 
causal pathways, such as inflammation, have also been investigated (Kiecolt-
Glaser and Glaser, 2002). The association between chronic somatic 
conditions and depression is bidirectional, so that depression is also a risk 
factor for many somatic conditions, and worsens their prognosis (see 2.6.5). 
 
In a recent meta-analysis, both obesity (adjusted OR 1.6) and being 
overweight (adjusted OR 1.08) predicted the onset of depression (Luppino et 
al., 2010). High consumption of processed foods is also a risk factor for later 
development of depressive symptoms, whereas a diet rich in vegetables, fruit 
and fish is a protective factor (Akbaraly et al., 2009). The Mediterranean diet 
and consumption of fruits and nuts, unsaturated fatty acids and legumes, in 
particular, seems to be protective against depression (Sanchez-Villegas et al., 
2009). In addition, leisure time physical activity unrelated to occupational 
activity appears to protect against psychological distress in men (Wiles et al., 
2007). A systematic review of diet and depression confirmed these findings, 
but methodological limitations of the studies and their limited evidence base 
raise cautions against making firm conclusions (Rahe et al., 2014).  
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Both alcohol use and alcohol use disorder (AUD) are associated with an 
increased risk of depression, of up to twofold in diagnosed AUDs (Boden and 
Fergusson, 2011). Cannabis use is also associated with an increased risk of 
depression, and there is a dose-response where heavy use (OR 1.6) implies a 
higher risk than light use (OR 1.2) (Lev-Ran et al., 2014). 
 
Finally, the association between smoking and depression is strong and well-
known. A systematic review of longitudinal studies concluded that the risk of 
developing depression among adolescent smokers was 1.7-fold, and the risk 
of taking up smoking among depressed adolescents 1.4-fold (Chaiton et al., 
2009). Also among adult smokers, the risk of developing depression is 
twofold, and smoking cessation could reduce this risk (Bakhshaie et al., 2015, 
Pasco et al., 2008). A twin modelling study concluded that there is both a 
causal relationship between nicotine dependence and development of 
depression and a shared genetic risk (Edwards and Kendler, 2012). 
2.4.5 OTHER PSYCHIATRIC DISORDERS AND PERSONALITY TRAITS 
 
Because there is some diagnostic overlap and common risk factors between 
depressive and other psychiatric disorders, it is understandable that the 
latter are also risk factors for developing depression. Anxiety disorders in 
particular are a risk factor for later onset of depression (Eaton et al., 2008c, 
Klein et al., 2013, Stegenga et al., 2013). Comorbidity with anxiety disorders 
may vary according to the diagnostic thresholds used, with lower diagnostic 
thresholds for MDD increasing comorbidity (van Loo et al., 2015b). 
 
Personality traits such as neuroticism also increase the risk of depression (De 
Graaf et al., 2002, Noteboom et al., 2015). A low sense of coherence, harm-
avoidance and low self-esteem are associated with increased incidence of 
depression (Lehtinen et al., 2005, Luutonen et al., 2011, Miettunen et al., 
2012, Miettunen and Raevuori, 2012). 
 
Subclinical depressive symptoms and general psychological distress (Ernst et 
al., 1992, Horwath et al., 1992, Klein et al., 2013, Skapinakis et al., 2006), as 
well as sleep problems (De Graaf et al., 2002, Riemann and Voderholzer, 
2003) indicate a risk of developing depression. It can be questioned whether 
these represent an independent risk factor or a marker of a premorbid state 
of depressive disorder. 
 
Finally, it is important to note that accumulation of several risk factors 
further increases the risk of depression (Meng and D'Arcy, 2014).  
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Table 5. Established risk factors of depressive disorders in longitudinal population studies 
Genetic and early life 
Biological factors Female sex  
(Anthony and Petronis, 1991, 
De Graaf et al., 2002, Eaton et 
al., 2001, Eaton et al., 2008c, 
Klein et al., 2013, Stegenga et 
al., 2013, Wang et al., 2010a) 
 Genetic risk  (Flint and Kendler, 2014) 
Early life and 
family 
Low parental education and occupational 
position  
(Park et al., 2013, Ritsher et al., 
2001) 
 Physical or sexual abuse (Stegenga et al., 2013) 
 Family history of MDE 
(Eaton et al., 2001, Klein et al., 
2013, Stegenga et al., 2013, 
Wang et al., 2010a) 
 Younger age (Eaton et al., 2008c, Stegenga et al., 2013, Wang et al., 2010a) 
Adulthood 
Personality  Neuroticism  
(De Graaf et al., 2002, 
Noteboom et al., 2015) 
 Harm avoidance (Miettunen et al., 2012) 
Socio-economic 
position Unemployment 
(Anthony and Petronis, 1991, 
Stegenga et al., 2013) 
 Financial strain  
(Lorant et al., 2007, Skapinakis 
et al., 2006, Stegenga et al., 
2013, Wang et al., 2010b, 
Weich and Lewis, 1998) 
 Low education  
(Wang et al., 2010b)(in the 
working population) (Stegenga 
et al., 2013) 
 Low income (among non-working population and working men)  
(Wang et al., 2010b) 
Social capital and 
relationships Separated or divorced  
(Anthony and Petronis, 1991, 
Lorant et al., 2007, Stegenga et 
al., 2013) 
 Social isolation  (Kaplan et al., 1987) 
 Low social participation  (Kivelä et al., 1996) 
 Negative life events  (De Graaf et al., 2002, Eaton et al., 2001) 
 Problems with neighbourhood  (Stegenga et al., 2013) 
 Low social support  (Stegenga et al., 2013) 
Other psychiatric 
disorders Depressive symptoms  
(Ernst et al., 1992, Horwath et 
al., 1992, Klein et al., 2013, 
Skapinakis et al., 2006, 
Stegenga et al., 2013) 
 Sleep problems   
(De Graaf et al., 2002) 
 Anxiety disorders, substance use and other psychiatric disorders  
e.g. (Eaton et al., 2008c, 
Stegenga et al., 2013) 
Poor physical 
health Poor perceived health  
(Kaplan et al., 1987) 
 Chronic somatic conditions 
(Kaplan et al., 1987, Patten, 
2001, Stegenga et al., 2013, 
Wang et al., 2010a) 
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2.5 PROGNOSIS OF DEPRESSIVE DISORDERS 
The average duration of a major depressive episode in population studies is 
3-4 months (Eaton et al., 2008b, Kessler et al., 2003, Spijker et al., 2002), 
but 15-20% have a chronic course of illness, lasting years (Eaton et al., 
2008b, Spijker et al., 2002). Based on an extensive literature review, the 
GBD study modelled the average episode duration of 37.7 weeks (8.7 
months) for MDD (Ferrari et al., 2013a). 
 
Dysthymia is a long-term illness. Although its duration is less well known 
than MDE, the median time to recovery is counted in years, not months 
(Klein et al., 2006). In its review, the GBD study found insufficient data to 
model duration and remission (Charlson et al., 2013).  
2.5.1 KEY CONCEPTS OF PROGNOSIS 
2.5.1.1 Remission, recovery and recurrence 
 
In a landmark paper from 1991, a task force of the MacArthur Foundation 
Research Network on the Psychobiology of Depression (Frank et al., 1991), 
proposed definitions of key concepts of major depressive disorder as follows: 
 
Remission: a brief period (x to z days) during which the individual no 
longer meets syndromal criteria for the disorder and has only minimal 
symptoms. 
 
Recovery: Remission that has lasted z+1 days or longer. The concept 
refers to recovery from the episode, not the illness itself. 
 
Relapse: Return of symptoms that meet the syndrome criteria during the 
period of remission, but before recovery. Conceptually a relapse 
represents the return of the symptoms of a still ongoing episode. 
 
Recurrence: Appearance of a new episode of the disorder during recovery. 
 
The concept of “asymptomatic” can be operationalised as having 8 points or 
less on the BDI (21 questions) scale; 7 or less on the Hamilton Rating Scale 
for Depression; or a maximum of 2 symptoms on the Schedule for Affective 
Disorders and Schizophrenia (Frank et al., 1991). 
 
Frank et al. (1991) provide various suggestions for the time limits of 
remission and recovery. Suggested minimum duration for remission is 2 to 3 
weeks, whereas the maximum duration, and limit to recovery, could be 2-6 
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months. In a later analysis, 2 months was considered too short, as more than 
half of those in remission at 2 months still experienced a relapse within 18 
months. 4 or 6 months was recommended as the limit between remission 
and recovery (Furukawa et al., 2008). 
 
In the case of dysthymia, the GBD 2010 study defined remission as no longer 
meeting diagnostic criteria over a follow-up period of minimum 2 years 
(Charlson et al., 2013), but the concepts are less clearly defined than for 
MDD. 
2.5.1.2 Residual symptoms and psychosocial disability 
Residual symptoms or subthreshold symptoms refer to symptoms of 
depressive disorder that persist after an episode, when either the number or 
intensity of symptoms no longer meet diagnostic criteria. Sub-threshold 
symptoms are also associated with psychosocial disability (Judd et al., 
2000).  
 
Lowered psychosocial functioning is frequently found after a depressive 
episode, which could, in theory, result from three sources: residual 
symptoms; a permanent scarring effect; or a trait vulnerability that pre-
existed the depressive episode. Ormel et al. (2004) tested these hypotheses 
and found evidence both for trait effect, meaning that the premorbid 
psychosocial functioning was already lower among persons who later 
developed depression, and state effect, meaning that psychosocial 
functioning worsened significantly during the depressive episode and was 
related to symptom severity. Scarring, a low psychosocial functioning in the 
absence of depressive symptoms, only occurred in severe recurrent 
depression. 
 
In addition, cognitive impairment in the fields of executive function and 
attention often persists after remission from depression (Rock et al., 2014), 
although the cognitive impairment resulting from depression may be smaller 
in population samples than in clinical studies (Castaneda et al., 2008). 
Impaired cognition may in turn cause problems in psychosocial functioning 
(Papakostas and Culpepper, 2015). 
2.5.2 REMISSION, RECOVERY AND RECURRENCE IN POPULATION 
STUDIES 
 
Many of the longitudinal studies of general population samples that examine 
prognosis of depressive disorders were carried out several decades ago with 
now outdated methodology. In the Stirling County study, which began in 
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1952 and was followed up for 17 years, 75% of cases with baseline depression 
had a poor outcome or subsequent episodes, and 26% had a chronic course of 
illness (Murphy et al., 1986). The Zurich cohort study followed up a cohort of 
19 to 20-year-olds, and found that 47% of those with baseline depression 
received no diagnosis at any of the follow-ups during seven years (Vollrath 
and Angst, 1989). The Upper Bavarian Longitudinal Community Study 
followed a rural population in Bavaria, Germany, and found that, after 25 
years, 20% of those with pure depression at baseline still had depression, and 
73% had no depression or anxiety disorder (Fichter et al., 2010). A Swedish 
study with a very long follow-up of 30-49 years, found a recurrence rate of 
40%, and transition to other diagnoses in 21% of the sample (Mattisson et 
al., 2007). 
 
In the more recent population studies, the prognosis seems somewhat better. 
In the Netherlands, 21% of persons with pure (not comorbid) depressive 
disorder, and 35% of those with comorbid disorder, still had a depressive 
disorder at the seven-years follow-up (Rhebergen et al., 2011). In Canada, 
77% of persons with MDE had recovered by the 2-year follow-up (Fuller-
Thomson et al., 2014).  
 
Recovery rates in clinical studies have generally been lower than in 
population studies, with 45-50% at 2 to 5-year follow-up. (Holma et al., 
2008, Penninx et al., 2011, Stegenga et al., 2012). In a study of Finnish 
primary care patients with MDD, the median time to remission was 20 
months (Riihimäki et al., 2014).  
 
Also, when symptom scores such as the BDI are used as outcome measures, 
recovery rates are lower. Two studies in general populations in Finland found 
recovery, defined as non-symptomatic in the BDI scale, in 35% of the sample 
over a 2-year follow-up and in 46% over 9 years (Dowrick et al., 2011, 
Viinamäki et al., 2006b).   
 
It is commonly believed that approximately 50% of persons with a first 
depressive episode will have a recurrent episode. This figure may be lower in 
the general population and higher when specialised mental health care 
settings are studied (Hardeveld et al., 2010). In a Dutch general population 
sample, 13% had a recurrent episode within five years; 23% in 10 years; and 
42% in 20 years (Hardeveld et al., 2013). 
 
Dysthymia is considered a chronic, as opposed to episodic, disorder. In a 10-
year follow-up of patients with dysthymia, 74% achieved recovery, but 71% of 
them had a relapse. Median time to recovery was 52 months (Klein et al., 
2006). In a general population study, 65% of persons with initial chronic 
depression had recovered at three years (Agosti, 2014). 
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2.5.3 QUALITY OF LIFE IN PEOPLE RECOVERED FROM DEPRESSION 
During the symptomatic phase, persons with depressive disorders experience 
significant reductions in health-related quality of life (Saarni et al., 2007). It 
is unclear how much of this reduction persists after symptomatic recovery 
from the disorder. In a 6-year follow-up study, patients with initial 
depression achieved normal mood, functional capacity and life satisfaction 
(Koivumaa-Honkanen et al., 2008). On the other hand, in another 6-year 
follow-up study, women who recovered from depression continued to have 
lower health-related quality of life in the fields of social functioning and pain. 
Some of the association was mediated by sleep disturbance, which was an 
independent predictor of low health-related quality of life (Joffe et al., 2012). 
Finally, in an elderly population, there was a surprising temporal association 
between reduction in HRQoL and subsequent depressive symptoms, but not 
in the opposite direction (Hajek et al., 2015).  
2.5.4 PREDICTORS OF DIFFERENT NEGATIVE OUTCOMES 
 
Knowledge of factors that predict negative outcomes, such as chronicity, 
recurrence, higher disability or mortality in depressive disorders, could in 
theory be used to target more intensive treatment interventions to these 
high-risk groups. Attempts have been made to find markers that predict 
treatment response to antidepressants, but have so far produced few results 
that are applicable to clinical practice (Kuk et al., 2010). 
2.5.4.1 Individual characteristics 
The evidence on the impact of age and gender on prognosis of depressive 
disorders is inconclusive. Some studies have found younger persons to have a 
higher risk of non-recovery or recurrence (Eaton et al., 2008b, Holma et al., 
2008) while older age appears to be an indicator of chronicity in dysthymia 
in particular (Agosti, 2014, Klein et al., 2008, Penninx et al., 2011). Some 
studies have found women to have a worse prognosis (Spijker et al., 2001), 
but most have found no difference between genders. Being single (divorced, 
separated, never-married or widowed) is a consistent predictor of 
unfavourable outcomes (Agosti, 2014, Eaton et al., 2008b, Mueller et al., 
1999). Worsening of the economic situation during the follow-up is also 
associated with persistence of depressive symptoms (Viinamäki et al., 
2006a). 
 
Childhood adversities, in particular different forms of abuse, have been 
associated with longer duration of depressive symptoms, persistence and 
recurrence (Agosti, 2014, Dowrick et al., 2011, Fuller-Thomson et al., 2014, 
Gilman et al., 2013, Klein et al., 2008, Nanni et al., 2012, Rhebergen et al., 
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2011). Possible explanations for this, as suggested by Gilman et al. (2013), are 
that psychosocial stressors and their sequelae increase vulnerability to the 
impact of stress on psychopathology, and may also reduce the effectiveness of 
psychological treatments. Accumulation of several traumatic events during 
adult life is also associated with persistence of depressive symptoms 
(Tanskanen et al., 2004). Family history of depression, which may indicate 
both genetic risk and impact on childhood experiences, is another risk factor 
of persistence of depression (Dowrick et al., 2011). 
 
Despite the well-documented cross-sectional relationship between social 
capital and depression, few studies have investigated the impact of social 
capital on prognosis of depression. In a clinical setting, low social support 
and adverse life events were associated with more depressive symptoms at 
follow-up (Leskelä et al., 2006). 
2.5.4.2 Disorder characteristics 
The severity of the disorder is closely related to its outcomes, with more 
severe disorders (measured with symptom scales or according to DSM-
defined diagnostic criteria) and those with psychotic features being more 
persistent (Penninx et al., 2011, Spijker et al., 2001, Spijker et al., 2002, 
Viinamäki et al., 2006a). Psychiatric comorbidity, especially with anxiety and 
personality disorders, is also related to worse outcomes (Agosti, 2014, Holma 
et al., 2008, Klein et al., 2008, Murphy et al., 1986, Patten et al., 2010, 
Penninx et al., 2011, Rhebergen et al., 2011, Spijker et al., 2001, Spijker et al., 
2002, Viinamäki et al., 2006a). Personality traits such as neuroticism also 
predict worse outcomes (Rhebergen et al., 2009, Spijker et al., 2001). 
Finally, cognitive symptoms of depression, such as memory impairment and 
attention difficulties, have an adverse impact on the course of illness 
(McIntyre et al., 2013, Papakostas, 2014, Trivedi and Greer, 2014). 
Specifically, autobiographical memory deficits have been associated with 
recurrent depression (Talarowska et al., 2016). 
 
In terms of recurrence, the number of earlier episodes is the strongest 
predictor of a recurrent episode (Bulloch et al., 2014, Dowrick et al., 2011, 
Hardeveld et al., 2010). Regarding subtypes of depression (melancholic and 
atypical), it appears that severity is a more important predictor of outcomes 
than the subtype, although suicidal thoughts may persist longer in the 
melancholic subtype (Lamers et al., 2016). 
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2.6 EXCESS MORTALITY IN DEPRESSIVE, ANXIETY 
AND ALCOHOL USE DISORDERS 
Most psychiatric disorders have increased mortality, and the pooled all-cause 
mortality risk for all mental disorders is twofold compared to the general 
population (Walker et al., 2015). Two-thirds of these deaths are due to 
natural causes, and one-third to unnatural or unknown causes. With 14% of 
all global deaths attributable to mental disorders, they rank among the most 
important causes of mortality, contrary to what was previously believed 
(Walker et al., 2015). Most of the evidence is from high-income countries, 
but identical findings in terms of mortality risk and years of life lost are 
reported from low-income countries (Fekadu et al., 2015). 
 
In a meta-analysis, the median of years of life lost due to mental disorders is 
10 years (Walker et al., 2015), but higher figures, from 10-20 years, have 
been reported for any psychiatric disorder (Chang et al., 2011, Wahlbeck et 
al., 2011) and up to 28.5 years for schizophrenia (Olfson et al., 2015). In 
Finland, the gap in schizophrenia is somewhat smaller, at 16-17 years 
(Laursen et al., 2013). 
 
In a recent meta-analysis, the risk was highest for psychotic disorders (RR 
2.5) and lowest for anxiety disorders (RR 1.4) (Walker et al., 2015). 
Significantly higher risks have been reported for instance in personality 
disorders (SMR 5-6) (Björkenstam et al., 2015) and schizophrenia (SMR 3.7) 
(Olfson et al., 2015). However, the increased mortality is observed in all 
categories of mental disorders (Harris and Barraclough, 1998).  
 
Fortunately, there are indications that, in the Nordic countries, the mortality 
gap between people with mental disorders and the general population is 
decreasing (Gissler et al., 2013, Wahlbeck et al., 2011). 
2.6.1 EXCESS MORTALITY IN MAJOR DEPRESSIVE DISORDER 
 
Four recent extensive reviews have assessed excess mortality in major 
depressive disorder. First, the Global Burden of Disease study, based on its 
literature review, used an excess mortality risk of 1.9 in its epidemiological 
modelling (Ferrari et al., 2013a). Second, a meta-analysis of 21 population-
based studies found an RR of 1.91 in MDD (Baxter et al., 2011). Third, in a 
meta-analysis of 203 studies covering different mental disorders, the 
mortality risk for depression was 1.7-fold (Walker et al., 2015). 
 
A fourth large meta-analysis of 293 studies (Cuijpers et al., 2014a) found a 
relative mortality risk of 1.64, which decreased to 1.52 when corrected for 
publication bias. This was lower than the RR 1.8 reported in an earlier meta-
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analysis of the same research team (Cuijpers and Smit, 2002). This study 
found that the longer the follow-up and the better the quality of the study, 
the lower the reported mortality risk. Cuijpers et al. therefore concluded that 
there is an elevated mortality risk in MDD, but this may have been 
exaggerated by publication bias and low-quality studies. 
 
Many good-quality individual studies and earlier reviews have found hazard 
ratios close to those reported in the recent meta-analyses, which are 1.5 to 1.9 
(Eaton et al., 2008a, Leinonen et al., 2014, Mykletun et al., 2009, Penninx et 
al., 1999). However, a large study of the Veterans Health Administration in 
the US found only a 17% increased risk, which was considered partially 
explained by the higher overall mortality of the studied group (Zivin et al., 
2015). Moreover, two large nationally representative community studies 
from North America did not find any independent risk after adjusting for 
sociodemographic differences, health behaviour and somatic health status 
(Everson-Rose et al., 2004, Patten et al., 2011). 
 
Most of the deaths are due to natural causes, but the relative risk is higher for 
unnatural deaths (Hiroeh et al., 2008, Walker et al., 2015). Increased risk 
has been found for circulatory diseases, respiratory diseases, diabetes, 
influenza and septicaemia (Leinonen et al., 2014, Nabi et al., 2010a, Zivin et 
al., 2015). Of unnatural deaths, the risk is increased not only for suicide 
(Leinonen et al., 2014, Nock et al., 2009, Zivin et al., 2015), but also other 
unnatural causes, such as homicide and accidents (Crump et al., 2013a, b). 
Cancer mortality appears not to be increased among the depressed (Leinonen 
et al., 2014, Zivin et al., 2015). 
 
It is unclear whether some subgroups of depressed people have higher 
mortality than others. However, a recent meta-analysis showed a higher risk 
among men (HR 2.0) than women (HR 1.6) (Cuijpers et al., 2014b). This was 
also found in a meta-analysis of studies among the elderly (Saz and Dewey, 
2001).  
2.6.2 EXCESS MORTALITY IN DYSTHYMIA 
 
There is a paucity of information about excess mortality in dysthymia. A 
literature review from 1998 found four studies reporting mortality risk in 
dysthymia. Combining the results, the overall risk of death was not 
increased, but the risk of unnatural causes was 4.5-fold, whereas the risk of 
natural death was 0.8-fold (Harris and Barraclough, 1998). More recently, 
the literature review carried out for the Global Burden of Disease 2010 study 
found only one meta-analysis, which consisted of two studies. No excess 
mortality in dysthymia was found (RR 1.37 95% CI 0.93–2.00) (Baxter et al., 
2011). 
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2.6.3 EXCESS MORTALITY IN ANXIETY DISORDERS 
 
Even though anxiety disorders are as common as depressive disorders, their 
impact on mortality is much less studied. A meta-analysis of mental 
disorders and mortality found a 1.4-fold risk of all-cause mortality in anxiety 
disorders, the lowest among the mental disorders studied (Walker et al., 
2015). Another meta-analysis reports an RR 1.9 for panic disorder based on 
four studies, and insufficient data for other anxiety disorders (Eaton et al., 
2008a). An earlier systematic review found two studies that reported no 
increase in all-cause mortality, but significant increase in unnatural deaths in 
anxiety neurosis (Harris and Barraclough, 1998). In panic disorder, all-cause 
mortality was twofold.  
 
Individual studies have found more mixed results. A population-based study 
in Norway found no increase in mortality after controlling for confounders. 
Interestingly, comorbid anxiety reduced the mortality risk in depression 
(Mykletun et al., 2009). Similarly, a study of elderly with anxiety and 
depression found no increased mortality associated with anxiety (Holwerda 
et al., 2007). In the Netherlands, however, anxiety was associated with 1.7-
fold mortality risk in men but not in women (van Hout et al., 2004) in one 
study, and 1.8-fold risk in women in another study (Denollet et al., 2009). In 
the US, the risk was elevated for both men and women (Ostir and Goodwin, 
2006). Of the specific anxiety disorders, generalised anxiety disorder (GAD) 
is associated with an increased cardiovascular mortality risk, even when 
controlled for comorbid depressive disorder (Martens et al., 2010). 
2.6.4 EXCESS MORTALITY IN ALCOHOL USE DISORDERS 
  
According to earlier meta-analyses, mortality in alcohol use disorders 
(alcohol abuse and alcohol dependence) is 1.8 to 2-fold (Eaton et al., 2008a, 
Harris and Barraclough, 1998). A recent meta-analysis of 81 studies found a 
twofold risk in general population studies, and a 3.4 to 4.6-fold increase in 
clinical samples (Roerecke and Rehm, 2013) Similarly, another new meta-
analysis of 39 studies found a high mortality risk ratio, of 3.45, compared to 
the general population, without distinguishing between different samples 
(Laramée et al., 2015). Few general-population studies have investigated 
mortality in alcohol use disorders controlling for confounders. A 14-year 
follow-up of a general population sample in Germany found 4.6-fold 
mortality in women and 1.9-fold in men (John et al., 2013). In Finland, 
mortality was 1.6-fold among persons with alcohol dependence and 20-fold 
in alcohol-induced psychosis (Perälä et al., 2010). 
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2.6.5 POSSIBLE MECHANISMS OF EXCESS MORTALITY 
 
Several mechanisms have been proposed to explain the excess mortality in 
depression, such as increased suicide rates and other unnatural deaths, 
unhealthy behaviours, biological dysregulation, poor access to or non-
compliance with medical treatment, and iatrogenic effects of psychiatric 
medications. However, the quality of evidence for these mechanisms varies, 
and even the causal directions of some of them are unclear (Cuijpers and 
Schoevers, 2004, Thornicroft, 2011). 
2.6.5.1 Suicide and other unnatural deaths 
In a Swedish longitudinal study with 50 years follow-up, the lifetime suicide 
risk for persons with affective disorders was 6%, much higher than the 0.3% 
of the population without mental disorders (Holmstrand et al., 2015). In 
men, the risk was 8.4-fold and in women 2.6-fold compared to the 
population without mental disorders. In a Danish register-based study with 
median follow-up of 18 years, 6.7% of depressed men and 3.8% of depressed 
women committed suicide during the follow-up (Nordentoft et al., 2011). 
Among people with depression, men, those with more severe depression, 
hopelessness, previous suicide attempts and psychiatric comorbidities have a 
higher suicide risk (Hawton et al., 2013). Suicides account for 12-13% of the 
excess deaths among depressed outpatients (Moustgaard et al., 2013). 
Suicide attempts are much more frequent than completed suicides. In a 
follow-up of depressed patients treated in secondary care, there were 10 
attempts per 100 patients annually, although many patients had more than 
one attempt (Holma et al., 2010).  
 
In addition to suicide, the risk of homicidal death is 2.6-fold and the risk of 
accidental death 2.2 to 2.5-fold (Crump et al., 2013a, b). However, even 
though the risk of unnatural deaths is increased, in absolute terms they 
account for a minority of all deaths. 
2.6.5.2 Depression and coronary heart disease 
As discussed in 2.4.4, links between depression and many somatic diseases 
are bidirectional. Depressed persons have a 30% increased risk of both 
coronary heart disease and myocardial infarction (Gan et al., 2014). Among 
patients with acute coronary heart syndrome, depression is an independent 
risk factor for adverse outcomes such as all-cause and cardiac mortality 
(Lichtman et al., 2014, Whooley and Wong, 2013). Both behavioural (e.g. 
physical inactivity, medication nonadherence, smoking, poor diet and social 
isolation) and biological mechanisms (autonomic nervous system activation, 
systemic inflammation, activation of the HPA axis, stress-induced ischemia, 
 51 
platelet activation, endothelial dysfunction and common genetic risk factors) 
are listed as potential mechanisms. According to some trials, antidepressant 
medication potentially improves cardiac outcomes (Whooley and Wong, 
2013). 
 
In addition to heart disease, MDD is a risk factor for other physical diseases. 
In the WMHS study, MDD predicted onset of all of the ten somatic 
conditions studied, including arthritis, diabetes, asthma, peptic ulcer and 
cancer (Scott et al., 2015). 
2.6.5.3 Hazardous health behaviours 
The association with many hazardous health behaviours and depression is bi-
directional. These behaviours increase the risk of depression, as described in 
2.4.4, and depression increases the risk of taking up or continuing such 
behaviours. 
 
As noted before, there is a two-way association between smoking and 
depression. Depressed persons have a higher risk of taking up smoking 
(Chaiton et al., 2009), and a 2-3 fold risk of relapse after quitting smoking 
(Zvolensky et al., 2015). In addition, there might be risk factors that increase 
the likelihood of both smoking and depression (Boden et al., 2010, Dierker et 
al., 2002, Edwards and Kendler, 2012). Alcohol consumption is also higher 
among depressed persons (Cuijpers and Schoevers, 2004). In fact, in a study 
of 40-64-year old Finnish people, alcohol-related causes of death accounted 
for 50% of the excess mortality in depressed men, and 30% in women 
(Moustgaard et al., 2013). 
 
Besides smoking, depression is associated with unhealthy diets, higher body-
mass index, metabolic syndrome, lower HDL cholesterol and reduced 
physical activity, all of which directly contribute to mortality (Cuijpers and 
Schoevers, 2004, Lehto et al., 2008a, Lehto et al., 2008b). Those with more 
severe symptoms and comorbidities are more likely to experience major 
weight gain (Heiskanen et al., 2013). All of these health behaviours are also 
risk factors for depression (Luppino et al., 2010, Wiles et al., 2007). 
 
 It has been suggested that the link between depression and many of its 
behavioural and other physical risk factors is a systemic inflammatory 
process (Berk et al., 2013, Kiecolt-Glaser et al., 2015). Psychosocial stressors, 
for example, increase levels of pro-inflammatory cytokines (Berk et al., 2013, 
Kiecolt-Glaser et al., 2015). In addition, sleep deprivation, poor diet and lack 
of exercise impact both immune function and systemic inflammation, and 
obesity itself is a state of systemic inflammation (Berk et al., 2013). These 
pathways are closely related to increased mortality, as discussed below.  
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2.6.5.4 Biological dysregulation 
Three main biological mechanisms have been proposed to explain the higher 
somatic morbidity and mortality among persons with depression: neuro-
immune dysregulation, hyperactivity of the HPA axis, and 
sympathoadrenergic dysregulation. However, the causal and temporal 
relationship between these mechanisms and depression is not entirely clear 
(Cuijpers and Schoevers, 2004). 
 
First, depression can stimulate the production of proinflammatory cytokines, 
which may in turn increase the risk of cardiovascular disease, diabetes, 
osteoporosis, arthritis and some cancers (Cuijpers and Schoevers, 2004, 
Kiecolt-Glaser and Glaser, 2002). The relationship between inflammation 
and depression is bidirectional (Kiecolt-Glaser et al., 2015) and is more 
closely related to the physical symptoms of depression: tiredness, sleep 
problems and lack of appetite (Jokela et al., 2015). Interventions that reduce 
inflammation markers include cognitive-behavioural therapy, exercise and 
meditation, and selective serotonin reuptake inhibitors (SSRIs) (Irwin and 
Cole, 2011, Vogelzangs et al., 2012). 
 
Second, hyperactivity of the hypothalamic pituitary adrenal (HPA) axis is 
observed in 50% of depressed individuals, and in 80% of those severely 
depressed (Anacker et al., 2011). The feedback regulation of the axis is 
impaired, likely due to the abnormal function of the glucocorticoid receptors 
(Anacker et al., 2011). As a result of the malfunction of this axis, 
hypercortisolemia in the blood is associated with insulin resistance, 
accumulation of intra-abdominal fat and lowered bone density (Cuijpers and 
Schoevers, 2004). The causal relationship between abnormalities of the HPA 
axis and depression has been unclear, and it has been suggested that both are 
caused by another factor, such as stress or trauma (Cuijpers and Schoevers, 
2004). However, increasing evidence suggests that malfunction of the HPA 
axis may play a causal role in the development of depression: for example, 
polymorphisms of the glucocorticoid receptors have been associated with 
increased incidence of affective disorders (Cuijpers and Schoevers, 2004). 
Glucocorticoid treatment sometimes induces depressive symptoms, and 
elevated glucocorticoid levels result may reduce hippocampal neurogenesis 
(Anacker et al., 2011). Differences between subtypes of depression have been 
documented, showing that persons with atypical depression might suffer 
from hypocortisolism, as opposed to the hypercortisolism seen in 
melancholic depression (Gold, 2015). 
 
Third, depression is associated with increased noradrenaline levels. The 
sympathoadrenergic dysregulation and autonomic hyperactivity can lead to 
reduced heart rate variability and increased risk of cardiovascular events 
(Cuijpers and Schoevers, 2004). 
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2.6.5.5 Antidepressants 
Concerns exist regarding the impact of antidepressants on mortality, and, in 
particular, the tricyclic antidepressants that have potentially dangerous side 
effects, including cardiac conduction abnormalities (Somberg and Arora, 
2008). At the population level, mortality among antidepressant users is 
higher compared to non-users, and increases further with use of other 
psychotropic medications (Palmaro et al., 2015, Sundell et al., 2011). 
However, in these register-based studies, users and non-users have different 
rates of depression, which makes interpretation of the results difficult. 
 
Among people with a previous suicide attempt, the use of selective serotonin 
reuptake inhibitors (SSRI) is associated with decreased all-cause mortality 
(RR 0.59) because of lower risk of cardiovascular and cerebrovascular deaths 
(Tiihonen et al., 2006). On the other hand, among elderly depressed persons, 
antidepressant users had a 1.7-fold mortality risk compared with non-users 
(Coupland et al., 2011). Again, in this naturalistic study, use of 
antidepressants could be an indicator of disorder severity, and the mortality 
risk could be attributable to the disorder itself. In summary, methodological 
challenges limit the conclusions that can be made regarding the impact of 
antidepressants on mortality. 
2.6.5.6 Health care utilisation 
Even though people with depression have higher prevalence of many chronic 
somatic conditions, they do not always receive adequate treatment for these 
conditions (Fagiolini and Goracci, 2009, Lawrence and Kisely, 2010). People 
with psychiatric disorders have fewer medical visits than the general 
population (Cradock-O'Leary et al., 2002), and their use of primary care and 
preventive services is particularly low (Salsberry et al., 2005). People with 
mental problems report more problems accessing general medical care than 
psychiatric care (Zeber et al., 2009). Reasons for not seeking help are related 
to lack of recognition of symptoms and the reluctance to seek care, lack of 
social support and isolation, and the cost of care, especially in settings where 
access to health care is associated with employment (Fagiolini and Goracci, 
2009, Zeber et al., 2009).  
 
The care received may be of worse quality than that provided to the general 
population. For example, patients with mental disorders and diabetes were 
less likely to receive appropriate laboratory and eye exams, and were more 
likely to be in poor glycaemic control than people without mental health 
problems (Frayne et al., 2005). People with mental illness are also less likely 
to receive invasive coronary interventions, and have increased cardiac 
mortality following cardiac events (Kisely et al., 2007, Mitchell and 
Lawrence, 2011). 
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The inequities in medical care received by people with mental disorders 
occur partly due to lack of information and communication problems with 
general healthcare workers, who might misattribute physical symptoms to 
mental disorder (Fagiolini and Goracci, 2009). Negative stereotypes may also 
lead to treating people with mental disorders less thoroughly (Thornicroft, 
2011).  
 
Finally, depressed persons are three times more likely to be nonadherent to 
their medication (DiMatteo et al., 2000). Three possible explanations for this 
are: 1) depressed persons are so hopeless that they do not develop positive 
expectations of the treatment, which would be important to achieve 
treatment adherence; 2) social isolation and the lack of family support that 
often follow from depression may negatively influence adherence; 3) 
problems in cognitive functioning and memory impairment in particular 
might be obstacles to adhering to treatment. 
2.7 SUMMARY OF THE LITERATURE REVIEW AND 
GAPS IN KNOWLEDGE 
While some issues regarding the prevalence, risk factors, prognosis and 
mortality in depressive disorders are relatively well-established and 
documented, the evidence is contradictory regarding others, and in some 
cases, there are apparent gaps in knowledge. 
 
Although it is clear that the annual prevalence of major depressive disorder is 
approximately 5% with wide global variations, it is not known to what extent 
non-participation in surveys influences prevalence estimates. There is little 
reliable and recent information on the prevalence of dysthymia, another 
important contributor to the burden of mental illness. It is also unclear 
whether there have been changes in prevalence rates in the past decade, as 
most studies on prevalence changes compare 1990s with the 2000s, or even 
earlier time points. 
 
Established risk factors of new-onset depressive disorders include female 
gender, childhood adversities (although this may be influenced by memory 
bias), chronic somatic conditions and other psychiatric disorders. The 
findings are inconsistent regarding the impact of marital and socioeconomic 
status, and very limited regarding social capital.  
 
Prognosis of MDD in population surveys appears rather good, with three 
quarters experiencing recovery. Less is known about the prognosis of 
dysthymia. Some factors – single marital status and disorder severity – have 
been consistently associated with worse outcomes, but results are mixed 
regarding the impact of age, gender, socioeconomic position and other 
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factors. The broader spectrum of outcomes, including consequences 
involving self-rated health, health-related quality of life and residual 
symptoms, is less well documented than remission and recovery. 
 
Finally, while the mortality risk in depressive disorders is estimated to be 
twofold, more recent and better studies report lower estimates. It is unclear 
whether the mortality risk has been exaggerated by poor-quality studies, and 
whether the risk differs by gender. Much less is known about excess mortality 
in anxiety and alcohol use disorders, even though both disorder groups are 
major public health concerns. 
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3 AIMS OF THE STUDY 
The overall aim of this study was to examine prevalence, predictors and 
different adverse outcomes of depressive disorders in a general population 
setting. 
 
The specific aims were to: 
1. Establish the prevalence of depressive disorders (MDD and 
dysthymia) in the Finnish population in 2011, and assess possible 
changes in prevalence from year 2000 to year 2011 (Sub-study I) 
 
2. Examine risk factors for new-onset depressive disorders in an 11-year 
follow-up (Sub-study II) 
 
3. Investigate the long-term prognosis of depressive disorders in a 
population sample using various outcome measures, and examine 
different predictors of adverse outcomes (Sub-study III) 
 
4. Assess excess mortality associated with depressive, anxiety and 
alcohol use disorders and psychological distress and depressive 
symptoms, and describe the principal causes of death in a general 
population (Sub-study IV) 
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4 MATERIALS AND METHODS 
4.1 DATA SOURCES 
Data from the following sources were used in the study: the Health 2000 and 
Health 2011 population health surveys; the Finnish Care Register for Health 
Care; the Finnish Causes of Death Statistics held by Statistics Finland. 
4.1.1 HEALTH 2000 SURVEY 
 
The Health 2000 Survey is a nationally representative survey of the Finnish 
population (Heistaro, 2008). It was conducted in 2000-2001. A total of 
8,028 adults aged 30 years and over (the adult sample) were sampled using 
stratified two-staged cluster sampling. The sample frame was the population-
wide insurance database held at the Social Insurance Institution (Kela). In 
the first stage, 80 health centre districts (clusters) out of a total of 249 were 
sampled, 16 from each of the five main hospital districts of Finland. Out of 
these 80 clusters, 15 represented the largest cities in Finland, and the 
remaining 65 were sampled using systematic probabilities proportional to 
size design. In the second stage, individuals from these 80 clusters were 
sampled by systematic random sampling. Persons aged 80 and over were 
oversampled (2:1). In addition, a sample of young adults aged 18-29 
(n=1894) took part in the survey of young adults, which had a shortened 
version of the study protocol (Figure 1, Table 6). 
 
The adult sample study protocol consisted of a home interview, self-
administered questionnaires and a health examination. In total, 7419 persons 
(93%) participated in at least some part of the study. 
 
The study had the approval of the Ethics Committee of the Hospital District 
of Helsinki and Uusimaa. Written informed consent was obtained from the 
participants.  
4.1.2 HEALTH 2011 SURVEY 
 
The Health 2011 Survey is a follow-up study of the Health 2000 (Koskinen, 
2012). The whole sample of the Health 2000 Survey, consisting of people 
who were alive, living in Finland, and had not refused to participate, were 
invited to take part. The young adults sample from Health 2000, of people 
who were 29-40 years of age in 2011, was included. In addition, there was a 
new young adults sample (18-29 years) in the survey, but this was not 
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included in the current study. Data were collected between August 2011 and 
June 2012.  
 
The adult sample study population was 7,885 individuals, of whom 5,806 
(74%) individuals participated in at least one part of the study (Figure 1, 
Table 6). The study had the approval of the Ethics Committee of the Hospital 
District of Helsinki and Uusimaa. Participants provided written informed 
consent.  
 
 
 
 
Figure 1 Participation and non-participation in the Health 2000 and Health 2011 Surveys  
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Table 6. Study population and register data used in the four sub-studies 
 Health 2000 Health 2011 Register data 
Sub-study I 30 years and over, 
n=8028 
30 years and over, 
n=7885 
Care Register for Health 
Care (multiple 
imputation) 
Sub-study II 30-65 years without 
current or past 
depressive disorder, 
n=4057 
41 years and over, 
n=3862 
Care Register for Health 
Care (multiple 
imputation) 
Sub-study III 30 years and over with 
12-month depressive 
disorder, n=392 
41 years and over, 
n=5733 
Care Register for Health 
Care (multiple 
imputation), Finnish 
Causes of Death 
Statistics (vital status) 
Sub-study IV 30 years and over, 
n=8028 
- Finnish Causes of 
Death Statistics (vital 
status and cause of 
death) 
4.1.3 REGISTER DATA 
4.1.3.1 Care Register for Health Care (HILMO) 
The Finnish Care Register for Health Care, a continuation of the Hospital 
Discharge Register, is managed by the National Institute for Health and 
Welfare. It covers all hospitalisations in public and private hospitals in 
Finland.  Since information on specialised outpatient care was available only 
since 1994, it was not utilised in this study. In this study, Sub-studies I-III 
used information from the HILMO register for multiple imputation. 
Information on lifetime psychiatric hospitalisations of both participants and 
non-participants of the Health 2000 sample was obtained from the 
registerand used in the studies as presented in Table 7. Information was 
available from 1969 onwards. Lifetime instead of past-year hospitalisations 
were used because of the low number of past-year hospitalisations. 
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Table 7. Care Register for Health Care information used in Sub-studies I-III. 
Variable Details Sub-
study 
I 
Sub-
study 
II* 
Sub-
Study 
III 
Any psychiatric 
disorder by 2000 
Hospitalisations for any psychiatric disorder (F04-
F99; ICD-8 and ICD-9: 291-319) during 1969-2000 
X  X 
 
Schizophrenia 
by 2000 
Hospitalisations for schizophrenia (ICD-10: F20; 
ICD-8 and ICD-9: 295.0-295.3, 295.5, 295.6, 295.8, 
295.9) during 1969-2000 
X  X 
 
Non-affective 
psychoses by 
2000  
Hospitalisations for non-affective psychoses (ICD-
10: F22, F23, F24, F25, F28, F29; ICD-8 and ICD-
9: 295.4, 295.7, 297, 298, 299) during 1969-2000 
X  X 
 
Depressive 
disorders by 
2000  
Hospitalisations for depressive disorders (ICD-10: 
F32, F33, F341; ICD-9 (1987-1995) 2961, 3004A; 
ICD-8: 2960, 2962) during 1969-2000 
X  X 
 
Anxiety 
disorders by 
2000  
Hospitalisations for anxiety disorders (ICD-10: F40, 
F41, F42, F430, F431; ICD-9 and ICD-8: 3000, 
3002, 3003) during 1969-2000 
X   
Alcohol use 
disorders by 
2000  
Hospitalisations for alcohol use disorders (ICD-10: 
F10; ICD-9: 303, 3050, 291; ICD-8: 303, 291) 
during 1969-2000 
X  X 
 
Dementia by 
2000 
Hospitalisations for dementia (ICD-10: F00-F03; 
ICD-9 and ICD-8 290) during 1969-2000 
X  X 
 
Any psychiatric 
disorder by 2011 
Hospitalisations for any psychiatric disorder (F04-
F99; ICD-8 and ICD-9: 291-319) during 1969-2011 
X X   
Schizophrenia 
by 2011 
Hospitalisations for schizophrenia (ICD-10: F20; 
ICD-8 and ICD-9: 295.0-295.3, 295.5, 295.6, 295.8, 
295.9) during 1969-2011 
X  X 
 
Non-affective 
psychoses by 
2011  
Hospitalisations for non-affective psychoses (ICD-
10: F22, F23, F24, F25, F28, F29; ICD-8 and ICD-
9: 295.4, 295.7, 297, 298, 299) during 1969-2011 
X  X 
 
Depressive 
disorders by 
2011 
Hospitalisations for depressive disorders (ICD-10: 
F32, F33, F341; ICD-9 (1987-1995) 2961, 3004A; 
ICD-8: 2960, 2962) during 1969-2011 
X X  X 
 
Anxiety 
disorders by 
2011 
Hospitalisations for anxiety disorders (ICD-10: F40, 
F41, F42, F430, F431; ICD-9 and ICD-8: 3000, 
3002, 3003) during 1969-2011 
X  X 
 
Alcohol use 
disorders by 
2011  
Hospitalisations for alcohol use disorders (ICD-10: 
F10; ICD-9: 303, 3050, 291; ICD-8: 303, 291) 
during 1969-2011 
X  X 
 
Dementia by 
2011 
Hospitalisations for dementia (ICD-10: F00-F03;x 
ICD-9 and ICD-8 290) during 1969-2011 
X 
 
 X 
 
*In Sub-Study II persons with hospitalisations due to depressive disorders prior to 2000 were 
excluded from the analyses and only hospitalisations between 2000-2011 were utilised in MI 
 61 
4.1.3.2 Mortality register (Sub-studies III-IV) 
Mortality data, including dates and causes of death, was obtained from the 
Causes of Death register from Statistics Finland (Finland, 2014). The data are 
compiled from death certificates, which are completed by the treating 
physician, or in the case of an unexpected or unnatural death, a medico-legal 
officer based on a forensic autopsy. This is the case in 25-30% of deaths, 
which is why Finnish mortality statistics are considered very reliable (Ylijoki-
Sorensen et al., 2014). 
4.2 THE CIDI INTERVIEW 
Psychiatric disorders in the Health 2000 and Health 2011 surveys were 
diagnosed with the Composite International Diagnostic Interview, Munich 
version (M-CIDI) (Wittchen and Pfister, 1997). When designing the Health 
2000 Survey, this was considered the best computerised version of the CIDI 
available. The Munich version was based on CIDI 2.1, the latest version at the 
time. 
 
The predecessor of CIDI is the Diagnostic Interview Schedule (DIS), the first 
fully structured psychiatric diagnostic interview that could be administered 
by trained lay interviewers (Andrews and Peters, 1998, Kessler and Ustun, 
2004). The CIDI was developed by an international task force, supported by 
the WHO and led by Dr. Robbins, the developer of the DIS. It was created in 
response to a need for reliable psychiatric instruments based on ICD criteria 
that could be used in population surveys to allow international comparison. 
The CIDI became available in 1990 and was used in several large population 
studies in its first years. The International Consortium in Psychiatric 
Epidemiology (ICPE) was created by the WHO to compare the results. To 
improve comparability of not only diagnoses, but also of risk factors, access 
to treatment and other important aspects of mental illness, the ICPE formed 
the WHO World Mental Health Survey Initiative and developed an improved 
and expanded version of the CIDI, the WMH-CIDI. The new version included 
modules covering functioning, treatment, risk factors, socio-demographic 
correlates and methodological issues, in addition to psychiatric diagnoses 
(Kessler and Ustun, 2004).  
 
The Munich version of the CIDI (M-CIDI) was developed parallel to CIDI 2.1, 
as there was a need to update the interview to correspond to DSM-IV 
diagnostic criteria, as well as some technical revisions. The development was 
done in collaboration with the WHO-CIDI consortium, and the M-CIDI 
corresponds closely to the WMH-CIDI. The M-CIDI has shown good test-
retest reliability (κ values 0.68 for major depressive disorder and 0.70 for 
dysthymia) in a sample of 60 persons aged 14-28 years, with a mean interval 
between interviews of 39 days (Wittchen et al., 1998). 
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The different versions of the CIDI are commonly used in general population 
mental health surveys (Kessler and Ustun, 2004), and international 
comparability is its major strength. It has shown good concordance with 
more thorough semistructured psychiatric interviews, such as the Structured 
Clinical Interview for DSM (SCID) (Andrews and Peters, 1998, Haro et al., 
2006). In an international validity study of the CIDI 3.0 (Haro et al., 2006), 
the sensitivity for any 12-month mood disorder was 69.1 and specificity was 
97.2, positive predictive value 49.6 and negative predictive value 98.7, with 
the SCID as comparison. In the National Comorbidity Survey (NCS-R), 
validity of the Major Depressive Episode module of the CIDI was assessed, 
with sensitivity of 54.6, specificity 94.7, total classification accuracy 90.7, 
positive predictive value 64.1 and negative predictive value 97.5 (Kessler et 
al., 2003). 
 
The M-CIDI has been compared to clinician diagnoses with excellent results: 
the sensitivity and specificity of the depression module were 95 and 100 for 
lifetime single and 93 and 100 for recurrent depressive episode, and 100 and 
85 for dysthymia, respectively, with corresponding Kappa values 0.96, 0.95 
and 0.54 (Reed et al., 1998). The lower Kappa value for dysthymia was due 
the M-CIDI not applying an optional hierarchy rule where a history of long 
unremitted MDD outweighs diagnosis of dysthymia. 
 
However, in the case of population studies, it can be argued that, in addition 
to individual-level concordance, a measure of aggregate-level concordance 
(i.e. agreement of prevalence rates of two different instruments) is important 
(Kessler et al., 2004). In the case of CIDI 3.0, there was no statistically 
significant difference between the 12-month prevalence rates produced by 
SCID or CIDI interviews, whereas lifetime prevalence of MDD was 33% 
higher when using SCID (Haro et al., 2006). 
 
The full M-CIDI interview lasts about 90 minutes, and had to be cut down for 
the Health 2000, as it was part of a more extensive general health survey. In 
2000, six sections were included: anxiety disorders, depressive disorders, 
mania, schizophrenia and other psychotic disorders, alcohol use disorders 
and other substance-related disorders. In addition, interviewer observations 
were recorded. In 2011, sections on mania and other substance-related 
disorders were not included, and the section on psychotic disorders was 
shortened. Altogether eight disorders were covered in both in 2000 and 
2011: panic disorder, agoraphobia, social phobia, generalised anxiety 
disorder, dysthymia, major depressive disorder, and alcohol abuse and 
dependence. Only 12-month prevalence was determined, except for alcohol 
use disorders, for which also lifetime prevalence was assessed. Diagnostic 
criteria of the DSM-IV were used. 
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The M-CIDI was translated from its English version into Finnish for the 
Health 2000 and pilot-tested. Test-retest reliability was assessed for the 
depression and dysthymia modules, and the inter-rater agreement was 
excellent with κ values 0.88 for both disorders and percentage of agreement 
94-98% (Heistaro, 2008). 
 
In Health 2011, the time available for the mental health interview was 
reduced further, and modules had to be prioritised based on their public 
health importance and experience from Health 2000. The sections assessing 
manic symptoms and substance use other than alcohol were omitted. The 
translation from Health 2000 was revised against the original German 
version and the English translation. The new CIDI was piloted and all errors 
were corrected before beginning the study. The interviewers, non-psychiatric 
health professionals, received a two-day training. The interview was carried 
out at the end of the health examination or, in some cases, during the home 
interview. The mean duration was 21 minutes, ranging from 2.6 to 176 
minutes. 
 
In 2000, a total of 6,005 CIDI interviews (75% of the sample) were 
conducted and in 2011, the total was 4,478 (57%). Altogether 3,584 people 
were interviewed both in 2000 and 2011. 
 
The Psychoses in Finland study was carried out parallel to the Health 2000 
Survey to identify persons with psychotic disorders (Perälä et al., 2007). 
Psychotic disorders were screened using the Composite International 
Diagnostic Interview, self-reported diagnoses, medical examination, and 
national registers on hospitalisations, medication and disability pensions. 
Lifetime diagnosis of psychotic disorders was established with the Research 
Version of the Structured Clinical Interview for DSM (SCID) and a review of 
medical records (First, 1997). In this study, people with a psychotic disorder 
were excluded from Sub-study II, and the results of Sub-studies III and IV 
were adjusted for psychotic disorders. In Sub-study III, the impact of 
comorbid psychotic disorder on the prognosis of depressive disorder was 
studied. 
4.3 STUDY VARIABLES 
4.3.1 OUTCOME VARIABLES 
4.3.1.1 Diagnostic status at follow-up (Sub-studies I-III) 
The presence of depressive disorders in 2011, MDD and dysthymia, was used 
as the primary outcome measure in sub-studies I-III. For both studies, these 
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were combined as a group, depressive disorders, containing people with 
MDD, dysthymia or both. 
 
Also, the presence of any depressive, anxiety or alcohol use disorder was 
considered as an outcome in Sub-study III.  
4.3.1.2 New-onset depression (Sub-study II) 
To analyse risk factors for incident or new-onset cases of depressive 
disorders only, people with a history of depressive disorder at baseline were 
excluded to the extent possible. People were excluded who in the Health 
2000 survey had received a 12-month diagnosis of MDD or dysthymia in the 
CIDI interview, had ever been hospitalised for a depressive disorder, or 
reported having received a depression diagnosis from a physician. People 
with any psychotic disorder in 2000 were also excluded, as they were 
considered to likely differ from the general population in terms of risk factors 
for onset of depression.  
4.3.1.3 Recovery and persistence (Sub-study III) 
Recovery was defined as not meeting diagnostic criteria for either MDD or 
dysthymia in the past 12 months. This is consistent with the definition of 
recovery presented by Frank et al. (Frank et al., 1991) where recovery is 
defined as having no symptoms or minimal symptoms for 4-6 months. We 
did not, however, take into account residual symptoms measured with the 
BDI, to allow comparison to other similar studies. 
 
Persistence of disorder was defined as having a depressive disorder both at 
baseline and follow-up. Since there was no information on the health status 
between these two timepoints, it could not be established whether this was a 
chronic, ongoing episode or a recurrent episode. The term “persistence” was 
chosen to reflect both options. 
4.3.1.4 Depressive symptoms and psychological distress (Sub-study 
III) 
The Beck Depression Inventory (BDI) was used to assess current depressive 
symptoms both at baseline and at follow-up (Beck et al., 1961). The 21-item 
version was used in 2000, and a shorter 13-item version, validated by Aalto 
et al., was used in 2011 (Aalto et al., 2012). The total score was divided into 
three categories, indicating no significant depressive symptoms, moderate, 
and severe depressive symptoms as follows: 0-9, 10-18 and 19 points or more 
in 2000, and 0-4, 5-8 and 9 or more points in 2011. 
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Current psychological distress was measured using the General Health 
Questionnaire (GHQ), where a score of 4 or more indicated psychological 
distress (Goldberg et al., 1997). 
 
It is noteworthy that the CIDI diagnoses covered the 12 months preceding the 
study, meaning that some persons had already recovered by the time of the 
interview. In contrast, the BDI and GHQ measured current symptoms. Both 
were part of a larger self-administered questionnaire sent to the participants 
to be comleted prior to the physical health exam. 
4.3.1.5 Health-related quality of life (Sub-study III) 
Health related-quality of life at follow-up was measured with the EQ-5D 
instrument, which was converted into an index score based on time-trade-off 
values elicited in a UK general population sample (Kind et al., 1999). 
4.3.1.6 Self-rated health (Sub-study III) 
Self-rated health at follow-up was measured by asking the respondents to 
assess their current health status by rating it as good, rather good, moderate, 
rather poor or poor. 
4.3.1.7 Mortality and causes of death (Sub-studies III-IV) 
Mortality data was obtained from the Statistics Finland Causes of Death 
Register, as described above. In Sub-study III, only information on vital 
status at the beginning of Health 2011 data collection (4 July 2011) was used. 
 
In Sub-study IV, date and cause of death were included in the analyses. The 
causes of death were categorised into natural deaths (ICD-10 codes A00-
R99), suicides (X60- X84), homicides (X85-Y09) and other unnatural 
deaths, such as accidents, injuries and poisonings (S00-T98, V01-X49 and 
Y40-Y98). The natural causes of death were further categorised into four 
classes: tumours (C00-D48), cardiovascular diseases (I00-I99), pulmonary 
diseases (J00-J99), and other (A00-B49, D50-H95, K00-N99, O00-R99). 
4.3.2 EXPOSURE AND CONFOUNDER VARIABLES AT BASELINE 
4.3.2.1 Sociodemographic variables (all Sub-studies) 
Sociodemographic information was obtained in a structured interview. 
Educational level, based on the highest level completed, was divided into 
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three categories: basic (no high school or vocational training); secondary 
(high school or completed vocational school); and higher (degree from a 
higher vocational institution, polytechnic or university). Marital status was 
categorised into married and cohabiting; and single, which included those 
never-married, divorced or widowed. Family income was obtained from 
registers of the Finnish Tax Administration, adjusted for family size, and 
divided into quintiles.  
4.3.2.2 Childhood adversity (Sub-studies II-III) 
Childhood adversities were elicited using an 11-item questionnaire “When 
you think about your growth years, i.e. before you were aged 16, did you…?”, 
with answer options “yes”, “no” or “cannot say” (Pirkola et al., 2005a). The 
items inquired were 
 
1. Did your family have long-term financial difficulties? 
2. Were your father or mother often unemployed although they wanted to 
work? 
3. Did your father or mother suffer from some serious disease or 
disability? 
4. Did your father have alcohol problems? 
5. Did your mother have alcohol problems? 
6. Did your father have any mental health problem, e.g., schizophrenia, 
other psychosis, or depression? 
7. Did your mother have any mental health problem, e.g., schizophrenia, 
other psychosis, or depression? 
8. Were there any serious conflicts within your family? 
9. Did your parents divorce? 
10. Were you yourself seriously or chronically ill? 
11. Were you bullied at school? 
 
The total number of reported adversities was counted and categorised into 0, 
1-2 and 3 or more reported adversities, as in Kananen et al. (2010). In sub-
study II, parental mental health problems (items 6 and 7) were included in 
the models separately, and not included in the summary variable. In sub-
study III, they were first explored separately in the unadjusted logistic 
models, and then included in the summary variable in the adjusted logistic 
models. 
4.3.2.3 Social capital (Sub-studies II-III) 
Social capital was conceptualised as a three-dimensional measure, assessing 
social support, social participation and trust, based on the work by Nieminen 
et al. (Nieminen et al., 2008). These dimensions concur with those proposed 
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by a broad international consensus (Zukewich and Norris, 2005). The 
indicator was created using factor analysis to divide 39 variables into the 
three chosen dimensions. The items included in the three dimensions are 
listed in Table 8. 
 
The dimension of trust included questions about feeling safe in the 
neighbourhood, disappointments caused by people close to you, and cynical 
mistrust, which was measured on an eight-item scale, shortened from the 
Cook-Medley hostility scale (Nieminen et al., 2008).  
 
 
Table 8. Items in the three dimensions of the social capital measure (adapted from 
Nieminen et al. (2008)) 
Social support Social networks and 
participation 
Trust 
People on whose help you 
can count when you feel 
exhausted 
Club and society activities Feeling safe in neighbourhood 
People you think really care 
about you no matter what 
Theatres, movies Feeling safe walking out alone 
after 10 p.m. 
People that can really make 
you feel better when you feel 
down 
Studying Cynical mistrust (8 questions) 
People from whom you get 
practical help when needed 
Church and religious activities Been surprised by the 
behaviour of people you 
thought you knew well 
 Exercise, fishing, gardening 
etc. outdoor activities 
People you counted on 
disappointed you 
 Handicrafts, playing music, 
singing 
 
 Visiting family, friends or 
neighbors 
 
 Having family, friends or 
neighbours visit you 
 
 Talking on the phone  
 Joining in any health 
promotion/discussion group 
(11 questions about health 
promotion) 
 
4.3.2.4 Somatic comorbidity, smoking and obesity (Sub-studies II-IV) 
Somatic comorbidity was assessed based on self-reported diseases that had 
been diagnosed by a physician. At baseline, participants were asked whether 
they had received diagnosis from a doctor for 43 different conditions, and in 
some cases, to provide details on treatment and intensity of the condition. 
For this study, 24 conditions were chosen based on relevance to mortality 
and comorbidity, and the reliability of self-report (Saarni et al., 2006). These 
were categorised into eight groups: cardiovascular diseases (heart failure, 
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myocardial infarction, coronary heart disease, hypertension and stroke); 
pulmonary diseases (chronic obstructive pulmonary disease, chronic 
bronchitis and asthma); neurological diseases (migraine, Parkinson's 
disease); musculoskeletal disorders (rheumatoid arthritis, osteoarthritis, 
back or neck disease requiring a visit to a physician in the past 12 months); 
vision and hearing disorders (unoperated cataract, glaucoma, macular 
degeneration, hearing loss, tinnitus), and other diseases (disturbing allergy 
requiring a visit to a physician in the last 12 months, psoriasis, inflammatory 
bowel disease and urinary incontinence). Cancer and diabetes were included 
separately. In Sub-studies II-III, somatic comorbidity was categorised into 0, 
1-2 and 3 or diseases, whereas in Sub-study IV, the eight categories were 
included as such. 
 
Participants were classified into three categories based on smoking status: 
current smokers (smoked at least 100 times in their lifetime, smoked 
regularly for the past year, and most recently during the past month), ex-
smokers, and non-smokers. 
 
Body-mass index (BMI) was calculated based on height and weight 
measurements at the health examination. 
4.4 STATISTICAL METHODS  
In all sub-studies, sociodemographic and other baseline characteristics were 
compared among different subgroups using the chi-square test for 
categorical and t-test for continuous variables. All tests were two-tailed, and 
p-value of <0.05 was chosen to denote statistical significance. The stratified 
two-stage cluster sampling was accounted for by using survey procedures of 
the statistical software. Weights were used to adjust for the oversampling of 
individuals aged 80 and over, where the analytic sample was not limited to 
younger individuals. 
 
The R statistical software (version 3.1 for Linux) was used to carry out 
multiple imputation. Other analyses, including analysis of the imputed data 
in Sub-studies I-III, were done using the Stata statistical software package 
(version 11.2 for Windows). 
4.4.1 MULTIPLE IMPUTATION 
 
Participation in the Health 2011 was much lower than in Health 2000, at 
73% vs. 93%, and participation in the CIDI, in particularl was low, at 75% vs. 
57%. From previous studies, it was known that attrition is selective, and 
persons with mental disorders have a lower likelihood of participating. 
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Therefore, this non-participation needed to be accounted for. Two methods 
were compared: inverse probability weights (IPW) and multiple imputation 
(MI). IPW are technically easier to apply and are more frequently used, but 
the MI is more efficient and flexible (Härkänen et al., 2016, Li et al., 2015, 
Mackinnon, 2010, Rubin, 1978).  
 
Multiple imputation replaces the missing values by numbers based on 
associations among the observed values in the data set (Li et al., 2015). This 
process of generating the replacement values is repeated many times, 
producing several copies of the original data sets, but with no missing values. 
Then, the imputed data sets are analysed separately according to the desired 
statistical analysis, such as regression, and finally the results are combined 
into a single estimate. As opposed to other forms of imputation (such as 
means or single imputation), it does not create false precision in the data. 
 
In this study, register data on hospitalisations for psychiatric disorders, as 
presented in Table 7, and information from the Health 2000 interview was 
utilised in the multiple imputation. In Sub-study I, the criteria for including 
variables into the imputation model were that they had to have more than 5% 
points more observed values than the outcomes and a Pearson correlation 
higher than 0.20 with the outcomes. In Sub-studies II-III, the register 
variables with highest correlation, as well as all the variables from the 
regression models were included. The exact variables used for each of the 
Sub-studies I-III are reported in the Supplementary tables of the studies. 
 
The MI was based on chained equations (ICE) (van Buuren and Groothuis-
Oudshoorn, 2011) and regression trees (Therneau et al., 2015) suitable for 
imputing categorical variables, such as the needed outcome variables: MDD 
and dysthymia diagnoses. In Sub-study I, both baseline and follow-up 
datasets were imputed simultaneously, by groups defined by age and gender. 
A total of 20 imputed data sets were constructed in Sub-study I; 24 in Sub-
study III; and 35 in Sub-study II. 
 
In Sub-Study I, the MI was based on the total sample of Health 2000 (a total 
of 8,028 people) whereas in Sub-Study II, it was based on the sample of 
4,057 participants without depression at baseline, and in Sub-Study III, on 
the 7,112 people who participated in at least some part of the study. It was 
considered that imputing all the missing values would not have reflected true 
associations in the group of nonrespondents.  
4.4.2 WEIGHTS 
 
Multiple imputation was compared to the more traditional method of 
accounting for non-response, inverse probability weights, which were applied 
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in the Health 2011 Survey. Their purpose is to generalise the data to 
represent the survey’s target population, and adjust for the effect of non-
participation. Inverse probability weights were created using the 
participation probabilities estimated by a logistic regression model, which 
were then calibrated with respect to known population distributions, such as 
age and gender distributions. Sociodemographic information from Statistics 
Finland and data from the baseline survey were used for this purpose, 
whereas disease-specific information from the Care Register for Health Care 
was not used. 
 
In the Health 2000 Survey, poststratification weights were applied. They 
were based on the design weights, which are simply the inverse of the 
inclusion probability of an individual. They were then calibrated using 
poststratification according to known population characteristics: health care 
district, university hospital district, age, gender and mother tongue 
(Heistaro, 2008). 
 
Design weights to account for the oversampling of individuals aged 80 and 
over were also used in the MI analyses (Sub-studies I and III) 
4.4.3 SUB-STUDY I 
 
In Sub-study I, age and gender adjusted prevalences were estimated using 
the predictive margins method (Lee, 1981). Prevalences in 2000 and 2011 
were compared by adjusting for changes in the population so that the 
standard population was chosen to be the 2011 population. This allowed for 
analysis of time trends taking into account the changes that had occurred in 
the age and gender distribution of the Finnish population. Logistic bivariate 
and multivariate regression was used to analyse associations between 
independent and dependent variables. 
 
We used two methods to adjust for non-response: inverse probability 
weighting (IPW) and multiple imputation (MI). 
4.4.4 SUB-STUDY II 
 
Logistic bivariate and multivariate regression models were used to analyse 
risk factors of new-onset depression (MDD or dysthymia) in the working-
aged population (30-65 years at baseline). Six regression models were built 
by subsequently adding new risk factors and confounders to those of the 
previous model: 1) age and sex; 2) education, income and marital status; 3) 
childhood adversities and paternal mental disorder; 4) social capital; 5) 
somatic diseases; 6) mental health (anxiety and alcohol use disorders, 
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baseline depressive symptoms). Separate multivariate regression models 
were built to analyse risk factors for MDD only and dysthymia only, where 
only models 1 and 6 were used. Multiple imputation was used to handle 
missing data. 
4.4.5 SUB-STUDY III 
 
In Sub-study III, prevalences with their corresponding confidence intervals 
were used to describe diagnostic status at follow-up in the baseline MDD and 
dysthymia groups. Proportions and means were used to describe depressive 
symptoms, psychological distress, quality of life and self-rated health at 
follow-up in the two groups. These were further stratified into those who had 
recovered (no depressive, anxiety or alcohol use disorder at follow-up) and 
those who had not. 
 
Logistic multinomial regression models were built to analyse associations 
between the predictors and two outcomes: death and persistence of 
depressive disorder. This was done to account for the impact of right 
censoring, where participants with the most severe disorder possibly also 
have the highest mortality risk. In the multinomial regression, the two 
outcome categories were compared against the reference category “alive and 
without depressive disorder.” 
 
Linear regression was used to analyse depressive symptoms at follow-up 
based on the BDI-13 score. Upon analysing the linear regression model, 12 
possibly outlying individuals were found and the analyses were performed 
excluding them, which did not impact the results. 
 
Multiple imputation was used to account for missing data. 
4.4.6 SUB-STUDY IV 
 
In Sub-study IV, analyses were limited to age group 30-70 years, as 
participation in the CIDI interview in the older age groups was low, which 
could have distorted the results. Cox’s proportional hazards regression model 
was used to examine the risk of all-cause mortality. Four regression models 
were built to examine the impact of different confounders: 1) adjusting only 
for psychiatric comorbidity; 2) adjusting for marital status, education and 
income; 3) adjusting for health and health behaviour; 4) combining all 
confounders from models 1-3. All models were stratified for age and sex. 
 
The models were tested to verify the proportional hazards assumption. This 
did not hold for the variable describing history of cancer diagnosis (p-value 
Materials and methods 
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0.044), because the mortality risk of persons with diagnosed cancer was high 
at the beginning of the follow-up and then decreased to level of risk close to 
the cancer-free population. Therefore, cancer diagnosis was added to the 
models through stratification, not direct adjustment.  
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5 RESULTS  
5.1 PREVALENCE OF DEPRESSIVE DISORDERS (SUB-
STUDY I)  
In 2011, the 12-month prevalence of MDD was 7.4% (95% CI 5.7-9.0); higher 
in women (10.0%, 95% CI 8.2-11.8) than men (4.4%, 95% CI 2.1-6.7); and 
higher in the 30-44 year age group (9.6%, 95% CI 7.1-12.1). The prevalence of 
dysthymia was 4.5% (95% CI 3.1- 5.9) in the general population, with no 
significant gender or age differences (Table 9). 
 
In adjusted logistic regression, female gender (adjusted OR 2.3, 95% CI 1.58-
3.44), younger age, and being single (adjusted OR 1.5, 95% CI 1.19-2.01) were 
associated with a higher prevalence of MDD. Education was not associated 
with prevalence of MDD (Table 10). 
 
Correlates of dysthymia in the adjusted logistic regression were low 
education and being single (adjusted OR 2.5, 95% CI 1.55-3.95) (Table 10, 
Markkula et al., previously unpublished results). 
 
The prevalence of MDD, adjusted for sociodemographic changes that 
occurred in the population, increased in women by 2% points and in men by 
0.9% points. This was significant in women (p=0.049), but not in men (p= 
0.777) (Figure 3). The prevalence of dysthymia did not change significantly 
(p 0.426 for total population). When combined, the prevalence of depressive 
disorders increased by 2.3% points in the total population, which was 
significant (p =0.014). The increase was significant in women (2.9% points, 
p=0.018), but not in men (1.6%, p= 0.323). 
 
Non-participation was selective, so that non-participants had higher 
prevalence of lifetime hospitalisations for depressive disorders than CIDI 
participants (3.8% vs. 1.7%, respectively). The difference was more marked in 
the age groups 65-74 years (3.6% vs. 1.6%) and 75 years and older (4.6% vs. 
1.4%). A total of 71% of persons with lifetime psychiatric hospitalisations and 
72% with lifetime hospitalisations for depressive disorders did not 
participate in the CIDI interview. Therefore, it is understandable that the 
prevalence rates based on MI utilising register data were higher than 
prevalence rates based on weights only. A comparison is presented in Table 
9. The increase was, on average, 2% points. The increasing trend in 
prevalence was similar when using weights: the increase in prevalence of 
MDD from 2000 (4.6%) to 2011 (5.3%) was not statistically significant 
(p=0.057), but still observed. 
  
Results 
74 
Table 9. 12-month prevalence of depressive disorders in Health 2011 by gender and age 
group, comparing multiple imputation (MI) and weights 
 Prevalence 
with MI 
95% CI with MI Prevalence 
with 
weights 
95% CI with 
weights 
Depressive disorders 9.6 7.9-11.3 6.8 6.0-7.5 
  Women 12.2 10.1-14.3 8.4 7.3-9.6 
  Men  6.7  3.8- 9.6 4.9 3.9-5.9 
   Age 30-44 years 12.5 10.1-14.9 9.4 7.6-11.3 
   Age 45-54 years 12.0  9.7-14.2 8.9 7.1-10.6 
   Age 55-64 years  7.0  4.1- 9.8 6.5 5.1- 8.0 
   Age 65-74 years  5.8  3.4- 8.1 3.2 2.0- 4.5 
   Age 75 and over  8.0  1.1-14.9 1.9 0.6- 3.2 
MDD 7.4 5.7- 9.0 5.4 4.7-6.1 
  Women 10.0  8.2-11.8 7.0 5.9-8.0 
  Men  4.4  2.1- 6.7 3.5 2.7-4.3 
   Age 30-44 years  9.6  7.1-12.1 7.8 6.1- 9.4 
   Age 45-54 years  9.2  7.2-11.2 6.9 5.3- 8.5 
   Age 55-64 years  5.1  3.3- 6.9 5.1 3.7- 6.4 
   Age 65-74 years  4.5  2.3- 6.6 2.6 1.5- 3.7 
   Age 75 and over  6.7  1.0-12.5 1.0 0.1- 1.9 
Dysthymia 4.5 3.1- 5.9 2.0 1.6-2.4 
  Women  4.3  3.0- 5.7 2.2 1.6-2.9 
  Men  4.7  2.4- 7.0 1.7 1.1-2.4 
   Age 30-44 years  4.5  2.6- 6.4 2.8 1.7- 3.9 
   Age 45-54 years  4.3  2.7- 5.9 2.7 1.8- 3.7 
   Age 55-64 years  4.2  2.0- 6.5 1.8 1.0- 2.5 
   Age 65-74 years  4.0  1.9- 6.1 0.8 0.2- 1.5 
   Age 75 and over  6.3  0.5-12.0 0.9 0.0- 1.9 
Table 10. Correlates of MDD and dysthymia in the Health 2011 Study 
 MDD, adjusted OR  
(95% CI)*  
Dysthymia, adjusted 
OR (95% CI)* 
Men 1 1 
Women 2.33 (1.58-3.44) 1.02 (0.62-1.70) 
Age 30-44 years 1 1 
Age 45-54 years  0.84 (0.63-1.13) 0.92 (0.55-1.54) 
Age 55-64 years  0.48 (0.34-0.70) 0.65 (0.33-1.31) 
Age 65-74 years 0.29 (0.17-0.51) 0.39 (1.14-1.02) 
Age 75 years and over 0.26 (0.07-0.91) 0.49 (0.13-1.83) 
Basic education 1 1 
Intermediate education 0.78 (0.55-1.11) 0.58 (0.34-0.99) 
High education 0.81 (0.57-1.17) 0.48 (0.28-0.83) 
Married or cohabiting 1 1 
Separated, widowed or unmarried 1.54 (1.19-2.01) 2.47 (1.55-3.95) 
*Adjusted for sex, age, educational level, marital status and region 
 75 
 
Figure 3 12-month prevalence of depressive disorders in the Finnish population in 2000 and 
2011  
5.2 RISK FACTORS OF DEPRESSIVE DISORDERS 
(SUB-STUDY II)  
At the follow-up, 104 new cases of MDD and 31 of dysthymia were diagnosed, 
9 of who had both diagnoses. Incidence of depressive disorders differed 
between subgroups, being highest among persons with anxiety disorders 
(13.7%) and those with high BDI score (11.5%). In the complete sample, 
incidence of new-onset depression was 4.4% (95% CI 3.6-5.2%). 
 
In the final adjusted logistic regression models, significant risk factors of 
new-onset depressive disorders were younger age, female gender, having 
three or more childhood adversities, low trust axis of social capital, anxiety 
disorder and depressive symptoms (Table 11). The predictors were different 
for the two depressive disorders. Risk factors for MDD were younger age (OR 
0.97, 95% CI 0.95-0.99 per year), female gender (OR 1.68, 95% CI 1.11-2.55), 
anxiety disorder at baseline (OR 2.53, 95% CI 1.17-5.46) and subclinical 
depressive symptoms (OR 1.64, 95% CI 1.00-2.68 for moderate and OR 3.03, 
95% CI 1.48-6.19 for severe depressive symptoms). Risk factors for 
dysthymia were younger age (OR 0.93, 95% CI 0.89-0.98 per year), three or 
more childhood adversities (OR 3.36, 95% CI 1.22-9.27), low trust axis of 
social capital (OR 0.30, 95% CI 0.09-0.97 for high trust) and chronic somatic 
diseases (OR 3.37 for 1-2 diseases, 95% CI 1.19-9.52). 
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Table 11. Incidence of depressive disorders by subgroup and adjusted odds 
ratio for new-onset depressive disorders in the Health 2011 Survey 
 Incidence of 
depressive 
disorders (%) 
P for 
difference  
Adjusted OR for 
depressive disorders  
(95% CI) 
Sociodemographic characteristics 
Age group: 30-44 5.4 0.033 0.97 (0.95-0.99)  
Age group: 45-54 4.2  (per year) 
Age group: 55-64 2.9   
    
Sex: male 3.5 0.018 1 
Sex: female 5.3  1.46 (1.01-2.12) 
    
Education: primary 3.6 0.420 1 
Education: secondary 4.7  1.27 (0.75-2.15) 
Education: tertiary 4.7  1.23 (0.73-2.09) 
    
Income: 1st quintile 4.3 0.974 1 
Income: 2nd quintile 4.8  1.23 (0.54-2.80) 
Income: 3rd quintile 4.0  0.99 (0.42-2.34) 
Income: 4th quintile 4.4  1.06 (0.46-2.47) 
Income: 5th quintile 4.5  1.17 (0.51-2.67) 
    
Marital status: married  4.4 0.838 1 
Marital status: unmarried 4.5  0.94 (0.56-1.61) 
Childhood adversities 
No adversities  3.5 0.001 1 
1-2 4.3  1.15 (0.78-1.70) 
3 or more 7.6  1.76 (1.10-2.83) 
    
Parental mental disorder 7.3 0.068 1.29 (0.66-2.53) 
Social capital 
Axis 1: support low  4.1 0.825 1 
Axis 1: support medium 4.4  1.06 (0.66-1.71) 
Axis 1: support high 4.6  1.07 (0.66-1.73) 
    
Axis 2: participation low  5.2 0.329 1 
Axis 2: participation medium 3.7  0.66 (0.41-1.07) 
Axis 2: participation high 4.5  0.74 (0.45-1.19) 
    
Axis 3: trust low  6.0 0.006 1 
Axis 3: trust medium 4.6  0.85 (0.55-1.30) 
Axis 3: trust high 2.9  0.58 (0.36-0.96) 
Somatic morbidity 
No somatic diseases 3.8 0.369 1 
1-2 somatic diseases 4.8  1.32 (0.88-1.97) 
3 or more somatic diseases 4.4  1.26 (0.60-2.90) 
Psychiatric morbidity 
BDI 0-9 3.8 <0.001 1 
BDI 10-18 6.7  1.65 (1.04-2.61) 
BDI 19 or more 11.5  2.49 (1.20-5.17) 
Anxiety disorder 13.7 <0.001 2.75 (1.36-5.56) 
Alcohol use disorder 6.0 0.375 1.32 (0.60-2.90) 
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5.3 PROGNOSIS OF DEPRESSIVE DISORDERS (SUB-
STUDY III)  
A total of 392 people had a depressive disorder at baseline, out of whom 245 
had MDD only, 94 dysthymia only and 53 both MDD and dysthymia. Of 
them, 40.2% had current severe depressive symptoms, measured with the 
BDI. 
 
At the follow-up, 20.9% of people with baseline MDD and 27.0% of people 
with baseline dysthymia still had a depressive disorder, and 33.8% and 
42.6% some depressive, anxiety or alcohol use disorder, respectively. 
Depressive symptoms were more common than diagnosis of depressive 
disorder: 47.6% of those with baseline MDD and 61.2% of those with baseline 
dysthymia still had significant depressive symptoms after eleven years (BDI-
13 5 points or higher) (Table 12).  
 
Table 12. Diagnostic status and depressive disorders after eleven years follow-up by 
baseline diagnosis of depressive disorder (MDD or dysthymia) 
Diagnosis at 
baseline 
No 
diagnosis 
in 2011  
% 
Any 
depressive, 
anxiety or 
alcohol use 
disorder in 
2011 
% 
MDD in 
2011 
% 
Dysthymia 
in 2011 
% 
Any 
depressive 
disorder  
% 
BDI-13 
score 5 
or more  
% 
MDD in 2000 
(n=298) 
66.2 33.8 16.0 8.1 20.9 46.5 
Dysthymia in 
2000 (n=147) 
57.4 42.6 16.4 13.4 27.0 61.1 
 
 
Also health-related quality of life, measured as the EQ-5D score, was lower 
than in the general population (Table 13). However, when separated by 
diagnostic status at follow-up, those who had recovered from MDD had 
values close to the general population, whereas those recovered from 
dysthymia still had lower quality of life and more depressive symptoms. 
 
Also poor or rather poor self-rated health was more common than in the 
general population: 16.7% of persons with baseline MDD and 28.6% of 
persons with baseline dysthymia rated their health as poor or rather poor, 
compared with 10.8% of the total sample. 
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Table 13. Depressive symptoms, quality of life and self-rated health of persons with MDD 
and dysthymia after eleven years follow-up 
 
  
All 
 
Baseline MDD 
 
Baseline dysthymia 
Recovered 
(no CIDI 
diagnosis 
in 2011) 
Any CIDI 
diagnosis 
in 2011 
Recovered 
(no CIDI 
diagnosis 
in 2011) 
Any CIDI 
diagnosis 
in 2011 
No significant depressive 
symptoms (BDI-13 score 
0-4) % 
75.4 65.4 27.3 53.3 18.0 
Moderate depressive 
symptoms (BDI-13 score 
5-8) % 
12.0 16.2 15.7 24.7 12.4 
Severe depressive 
symptoms (BDI-13 score 
9-39) % 
12.5 18.4 57.1 22.0 69.6 
Quality of life, EQ-5D (UK 
index, mean) 
0.81 0.80 0.72 0.73 0.65 
Self-rated health rather 
poor or poor % 
10.8 11.6 26.6 22.5 37.3 
 
Single marital status (adjusted OR 1.91, 95% CI 1.05-3.56) and symptom 
severity at baseline (adjusted OR 1.05, 95% CI 1.01-1.09 per one point 
increase in BDI) were associated with persistence of disorder. Symptom 
severity at baseline also predicted more depressive symptoms at follow-up. 
No other studied factors, such as age, gender, education, history of childhood 
adversity, social capital, somatic or psychiatric comorbidity, were statistically 
significant predictors of outcomes of depression. 
 
A total of 29 individuals with baseline MDD and 25 individuals with baseline 
dysthymia died during the follow-up. Older age, male sex and symptom 
severity as measured with the BDI were associated with higher mortality risk. 
 
The analyses were also carried out using weights to account for non-
participation, instead of MI. There were no important differences, but in the 
weighted models, also childhood adversity and low social capital were 
statistically significant predictors of poor outcomes of depressive disorders. 
All in all, the estimates were similar in direction and magnitude. 
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5.4 EXCESS MORTALITY IN DEPRESSIVE, ANXIETY 
AND ALCOHOL USE DISORDERS (SUB-STUDY IV) 
Altogether 323 deaths were observed over the eight-year follow-up period in 
the studied age group of 30-70-year-olds. Majority of deaths (82.9%) were 
natural, 11.7% were accidents, 5.1% (n=16) suicides, one homicide and one 
unknown. Of the 16 persons who committed suicide, five (38.5%) did not 
have a known psychiatric diagnosis, but many of them had more than one, 
the most common being MDD (5 persons), social phobia (5) and alcohol 
dependence (3). 
 
Depressive disorders were associated with an increased mortality risk (fully 
adjusted HR 1.97, 95% CI 1.15-3.39) (Table 14). The unadjusted HR was 2.4, 
and was more affected by adjustment to sociodemographic factors (HR 1.7) 
than for health status and smoking (HR 2.2). 
 
Among persons with anxiety disorders, a large share (50%) of deaths were 
unnatural, and in some disorders this figure was 80-100%. The mortality risk 
was increased (HR 2.32, 95% CI 1.35-3.96), but became statistically non-
significant when adjusted for psychiatric comorbidity, and remained non-
significant in further adjustments. 
 
Alcohol use disorders also had a high rate of unnatural deaths (47.6%), and 
were associated with significantly increased mortality risk (adjusted HR 1.72, 
95% CI 1.10-2.71). 
 
Also depressive symptoms, measured with the BDI, were associated with 
increased mortality, without controlling for psychiatric disorders and 
controlling for other confounders (HR 1.53, 95% CI 1.11–2.11 for BDI score 
10–18 and HR 1.77, 95%CI 1.09–2.86 for BDI score 19 or more).  
 
Figures 4-5 present survival curves for men and women with depressive, 
anxiety and alcohol use disorders, and without these disorders, adjusted for 
other risk factors (age, education, income, marital status, smoking status, 
BMI and somatic diseases (Markkula et al., previously unpublished results).  
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Table 14. Mortality risk by psychiatric disorder and gender in unadjusted and adjusted 
models after 8-year follow-up (results by gender previously unpublished)  
 
 
Unadjusteda 
Adjusted for socioeconomic 
factors, health status and 
smokinga 
Hazard ratio 
(95% CI) 
p-value Hazard ratio (95% 
CI) 
p-value 
Any depressive disorder 2.40 (1.52-3.78) <0.001 1.97 (1.15-3.39) 0.01 
   Men 2.78 (1.56-4.98) 0.001 1.84 (0.89-3.81) 0.099 
   Women 1.95 (0.97-3.94) 0.062 2.13 (0.92-4.92) 0.078 
Any anxiety disorder 2.32 (1.35-3.96) 0.002 1.20 (0.58-2.45) 0.62 
   Men 2.82 (1.50-5.30) 0.001 1.39 (0.60-3.18) 0.441 
   Women 1.46 (0.50-4.26) 0.490 0.83 (0.21-3.29) 0.791 
Any alcohol use disorder 2.55 (1.65-3.93) <0.001 1.72 (1.10-2.71) 0.02 
   Men 2.40 (1.52-3.76) 0.000 1.52 (0.94-2.46) 0.088 
   Women 5.43 (1.42-20.6) 0.013 3.48 (0.68-17.7) 0.133 
a. All models are stratified for age and sex. The adjusted model is also stratified for lifetime 
psychosis and history of cancer, and adjusted for education (low/intermediate/high), income 
quintile, marital status (married or cohabiting/other), smoking status (smoker/ex-
smoker/never-smoker), BMI (<25/25-30/ >30), and somatic diseases (pulmonary, 
cardiovascular, musculoskeletal, vision and hearing, neurological, diabetes and other 
(psoriasis, inflammatory bowel disease, urinary incontinence, disturbing allergy).  
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Figure 4 Survival curves of men with depressive, anxiety and alcohol use disorders 
 
 
Figure 5 Survival curves of women with depressive, anxiety and alcohol use disorders 
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6 DISCUSSION  
6.1 SUMMARY OF THE MAIN RESULTS 
This longitudinal population study of depressive disorders examined 
prevalence, predictors and different adverse outcomes of depressive 
disorders in a general population setting. Specifically, the aims were to 
establish the prevalence of depressive disorders (major depressive disorder 
and dysthymia) in the Finnish population in 2011, and to assess possible 
changes in prevalence since 2000; to examine risk factors for new-onset 
depressive disorders; to investigate the long-term prognosis of depressive 
disorders in the population and different predictors of adverse outcomes; 
and to assess excess mortality in depressive, anxiety and alcohol use 
disorders.  
 
The 12-month prevalence of depressive disorders in the Finnish general 
population aged 30 years and over was 9.6% (95% CI 7.9-11.3) in 2011. There 
was a significant increase in the prevalence from 2000 to 2011. Accounting 
for non-participation by multiple imputation increased the prevalence 
estimate by approximately two percentage points.  
 
Risk factors for new-onset cases of depressive disorders were younger age, 
female gender, childhood adversities, lower trust axis of social capital, and 
having an anxiety disorder or subclinical depressive symptoms at baseline. In 
addition, having somatic diseases was a risk factor for dysthymia. 
 
Of the persons with MDD at baseline, 34% still had some depressive, anxiety 
or alcohol use disorder after eleven years, and 48% had clinically significant 
depressive symptoms. Among those with dysthymia at baseline, the 
prognosis was worse: 43% had some depressive, anxiety or alcohol use 
disorder, and 61% had depressive symptoms at follow-up. Both groups also 
had worse health-related quality of life and self-rated health, indicating 
greater health needs. The difference to the general population was 
particularly noticeable among persons with baseline dysthymia. Unmarried 
persons and those with a more severe initial disorder had a higher risk of 
persistent course.  
 
Persons with depressive disorders had a twofold mortality risk, whereas the 
risk was 1.7-fold in alcohol use disorders and not increased in anxiety 
disorders, when adjusted for age, sex, socioeconomic status, physical health 
and health behaviours. The mortality risk was higher among depressed men 
and in those with a more severe disorder. 
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6.2 POTENTIAL RISK FACTORS AND PREDICTORS OF 
NEGATIVE OUTCOMES OF DEPRESSION 
6.2.1 GENDER AND AGE 
 
In this study, women had a higher prevalence of MDD but not dysthymia, 
and their adjusted odds for current (prevalent) MDD, but not dysthymia, 
were increased. The risk for new-onset MDD was 1.5-fold in women. 
Prognosis of depressive disorders did not differ by gender except for the fact 
that depressed men had a higher mortality risk than women. In the separate 
mortality analyses, however, the hazard ratios were of similar magnitude in 
both genders, suggesting that the excess mortality in depressed men reflected 
the gender gap in life expectancy in the general population.  
 
These findings are largely consistent with previous literature. Most studies 
have found women to have higher incidence of depression, approximately 1.5 
to 2-fold (De Graaf et al., 2002, Eaton et al., 2008c, Klein et al., 2013, 
Stegenga et al., 2013, Wang et al., 2010a). However, incidence of depression 
decreases in both genders after 30 years of age, and in the studied age group 
of 41-77 years, the gender difference is smaller than in young adulthood 
(Patten et al., 2016, Pedersen et al., 2014). Therefore, it is understandable 
that the risk difference was slightly smaller than in many studies examining 
younger populations.  
 
Both the World Mental Health Surveys and a US national population survey 
found a higher prevalence of dysthymia in women (Blanco et al., 2010, 
Seedat et al., 2009). This differs from our finding, but there are few other 
studies to compare with. According to a meta-analysis, the mortality risk in 
depression is twofold in depressed men compared with depressed women. 
Also, as compared with the general population, depressed men have a higher 
mortality risk (RR 2.0) than women (RR 1.6) (Cuijpers et al., 2014b). The 
higher mortality risk of men was observed in sub-study III (depressed men 
vs. depressed women) but not sub-study IV (depressed men and women vs. 
general population). 
 
Why is the prevalence of MDD higher in women than in men? The question 
can be approached by examining which factors influence the magnitude of 
the risk difference. The risk difference between men and women peaks at 20 
years; after 40 years, it is very small (Pedersen et al., 2014). Women’s higher 
risk thus appears to be related to different life stressors in adolescence and 
early adulthood. It has been suggested that the difference in early 
adolescence is related to: the differing ages at which boys and girls develop 
emotional maturity; the differences in the way boys and girls are brought up; 
and differing reactions to maternal depression and other negative life events 
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(Jenkins and Curwen, 2008, Zahn-Waxler et al., 2000). Biological 
differences also influence the risk of depression and other mental disorders 
in later life through epigenetic mechanisms (Kigar and Auger, 2013). 
Hormonal changes in a woman’s life, such as entering puberty, pre-
menstrual symptoms, perinatal depression and menopause, might also 
explain part of the higher prevalence (Buttner et al., 2013, Schiller et al., 
2015, Toffol et al., 2015). Estrogens have been suggested to increase the risk 
of depression via two pathways – interactions with neurotrophic factors, 
such as the brain-derived neurotrophic factor (BDNF), and their influence on 
the serotonergic system (Borrow and Cameron, 2014). Early menarche, for 
example, has been associated with increased risk of depressive symptoms in 
early adolescence (Joinson et al., 2013). On the other hand, longer duration 
of the reproductive period may protect against postmenopausal depression 
(Georgakis et al., 2016). 
 
As previously noted, risk factors for depression differ between genders, with 
personality and interpersonal factors being more important among women, 
and externalising psychopathology, history of depression and stressful events 
related to financial and occupational problems more important among men 
(Kendler and Gardner, 2014). In early adulthood, women report more life 
events prior to the onset of depression, but this difference disappears later in 
life (Harkness et al., 2010). It has been suggested that acute stressors 
increase the risk of MDD in women and substance use disorders in men, but 
the evidence to support this is mixed, and most likely the pathways are more 
complex than previously thought (Slopen et al., 2011).  
 
Between countries, the risk difference is higher in high-income countries (Rai 
et al., 2013). On the other hand, Seedat et al. (Seedat et al., 2009) found that 
the male-female difference decreased over time and was smaller where 
gender roles were more equal. They hypothesize that the increase in female 
employment opportunities and birth control has promoted women’s mental 
health and reduced exposure to stressors. 
 
Some of the higher prevalence of depression among women may be due to 
ways that depressive symptoms are conceptualised. For example, crying and 
loss of sexual desire are more frequent among women (Salokangas et al., 
2002). Consistent with this idea of different diagnostic thresholds, men who 
receive a diagnosis of a depressive disorder report more disability (Scott and 
Collings, 2010). The diagnostic criteria of depressive disorders, however, do 
not include these contentious symptoms, and it is unlikely that measurement 
bias would explain all of the gender difference in depression. 
 
The prevalence and incidence of depressive disorders decreased with age, 
with the exception of prevalence of dysthymia, which remained stable. This is 
understandable, given the long-term course of the disorder, and in line with 
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earlier literature (Eaton et al., 2008c, Kessler and Bromet, 2013, Stegenga et 
al., 2013, Wang et al., 2010a). Some of the decrease may be due to 
methodological issues: O’Connor and colleagues have shown that the rate of 
positive responses to the rather complicated CIDI screening questions shows 
a much steeper decline with age than responses to the simpler symptom-
related items of the interview or symptom scales (O'Connor and Parslow, 
2009, O'Connor and Parslow, 2010). Another consideration is the lower 
participation rate in the mental health interview by older individuals. 
Consistent with this, the prevalence rates in older age groups were influenced 
by multiple imputation more than the younger ones, and, at the same time, 
point estimates were less precise. 
 
Nonwithstanding the limitations of psychometric instruments, it is possible 
that the impact of stressors in different stages in life influences the incidence 
of depressive disorders. Also, some personality features that predispose to 
depression may become subtler with increasing age, such as issues with 
interpersonal relationships and self-image. When comparing variation of 
depressive symptoms over the life course, both mild and severe depressive 
symptoms are less frequent in older age groups relative to younger ones, 
whereas symptoms classified as “despondent” (or deeply hopeless) did not 
decrease with age (Mezuk and Kendler, 2012). 
6.2.2 SOCIOECONOMIC POSITION 
 
In this study, neither income nor education as measures of socioeconomic 
position (SEP) was associated with prevalence, incidence or outcomes of 
depressive disorders. The only exception was dysthymia, which was more 
prevalent among people with low education. A meta-analysis found a 1.8-fold 
prevalence and 1.2-fold incidence of depression among those with lowest SEP 
(Lorant et al., 2003), but many individual studies from high-income 
countries have found no association. It is possible that the lack of association 
in incidence in our study is explained by thorough controlling for 
confounders, such as physical diseases and childhood adversities. In our 
study population, educational attainment was strongly correlated with age, as 
the educational level of the Finnish population has risen significantly over 
the past decades (Statistics Finland, 2015). This may also partly explain our 
lack of significant associations with education, since depressive disorders 
were more common among the younger age groups. 
 
These results do not support the theory of direct causation from adult SEP to 
depression. On the other hand, childhood adversities, some directly and 
some indirectly linked to socioeconomic position, were a strong risk factor 
for depression. Similarly, in a study of Finnish adolescents, parental 
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socioeconomic position was strongly correlated with current depressive 
symptoms (Torikka et al., 2014). 
 
In another analysis of the working-age participants of the Health 2000 
Survey, low income, but not education or manual occupation, was associated 
with a 1.7-fold odds of current depressive disorders, when adjusted for age, 
gender and marital status (Pulkki-Råbäck et al., 2012). This finding, together 
with the fact that dysthymia was more prevalent among people with less 
education, could be interpreted to support the theory of selection: that 
depressive disorders cause downward movement on the socioeconomic scale, 
or prevent moving upwards. On the other hand, there could be common 
factors leading to both low SEP and depressive disorders. Finally, we did not 
specifically assess the impact of financial hardship, which has been a stronger 
predictor than objective measures of SEP (Skapinakis et al., 2006, Wang et 
al., 2010b, Weich and Lewis, 1998). 
6.2.3 CHILDHOOD ADVERSITIES AND FAMILY HISTORY 
 
In this study, an accumulation of three or more childhood adversities 
predicted onset of depressive disorders, particularly dysthymia. People with 
three or more childhood adversities also had a 1.9-fold risk for persistence of 
depressive disorder, but this association reduced and became non-significant 
after controlling for other confounding factors. Parental mental disorder was 
not associated with onset of depressive symptoms, but we were not able to 
examine the impact of parental depressive disorder specifically. Also, the 
information was based on self-report and only two questions, one on each 
parent’s mental health, and therefore is not as reliable as prospective studies 
with standardised psychiatric evaluations of the parents. In earlier studies, 
parental mental disorder has been a risk factor for depression (Eaton et al., 
2001, Klein et al., 2013, Stegenga et al., 2013). However, in one study, the 
impact was mediated through childhood maltreatment (Plant et al., 2015). 
 
The impact of childhood adversity on the risk of depression is well-known in 
the literature (Bowes et al., 2015, Park et al., 2013, Pirkola et al., 2005a, 
Ritsher et al., 2001, Sourander et al., 2015, Stegenga et al., 2013) (Elovainio 
et al., 2015), even though there is controversy over the reporting bias 
introduced by current depressive symptoms (Colman et al., 2015). In this 
study, this was not a problem, as in Sub-study II, the individuals did not have 
depression at baseline, when childhood adversities were inquired. However, 
there may have been memory bias, as the study participants were middle-
aged or older at the time of the interview. 
 
In two studies examining the link between childhood adversities and chronic 
depressive disorder or psychological distress, the association was mediated 
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through personality pathology, such as avoidant or generally maladaptive 
personality (Klein et al., 2015, Spinhoven et al.). In another study, the 
negative impact of childhood maltreatment on the course of depression was 
mediated by personality characteristics (Hovens et al., 2016). This could 
explain how the risk remains increased in midlife and even later. 
Furthermore, according to the interpersonal theory of depression, negative 
interpersonal events in childhood, such as exposure to bullying, represent a 
type of trauma which may lead to development of depression similarly to 
other traumatic events in life (Sourander et al., 2015). The cognitive theory 
suggests that peer victimisation, particularly verbal or relational, contributes 
to the development of negative self-cognitions, which predisposes a person to 
depression (Cole et al., 2014). 
  
It is worthwhile to note that we did not have information on childhood abuse, 
which has been found to be a particularly strong risk factor for depression. A 
meta-analysis of consequences of different types of abuse found the strongest 
influence on risk of depression in emotional abuse, followed by neglect and 
physical abuse (Norman et al., 2012). Our results show that an accumulation 
of other forms of adversity, perhaps considered more benign in nature, does 
considerably increase the risk of depression. It may be encouraging news to 
families who face adversities that according to our study, it was the 
accumulation of three or more adversities that significantly increased the risk 
of depressive disorders. 
6.2.4 MARITAL STATUS AND SOCIAL CAPITAL 
 
In this study, single marital status (i.e. being never married, divorced, 
separated or widowed) was associated with a higher prevalence, but not a 
higher incidence, of depression, in addition to an increased risk of 
persistence of the disorder. It seems that single people do not have a higher 
risk of developing depression, but that the higher prevalence is instead due to 
reduced chance of recovery. Depressed individuals may also have a higher 
likelihood of ending a relationship or not starting one, but this was not 
examined in this study. Other studies have shown that mental disorders 
reduce the chances of marrying and increase the risk of divorce (Breslau et 
al., 2011). 
 
The higher prevalence of depression among single people is in line with 
earlier literature (Kessler and Bromet, 2013), and some studies have also 
found higher incidence (Anthony and Petronis, 1991, Scott et al., 2010). 
Similar to our findings, other studies have found longer episode duration and 
a higher risk of recurrence among the unmarried (Eaton et al., 2008c, van 
Loo et al., 2015a). The association between marriage and depression also 
depends on customs and culture related to marriage: a study of married 
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Pakistani women showed that depression was associated with teenage and 
arranged marriage, and to different forms of abuse by the husband and his 
family (Ali et al., 2009). 
 
The increased risk of persistence of depression among the unmarried could 
be related to the detrimental effect of loneliness. Social isolation or loneliness 
is associated with depressive symptoms and to other negative health 
outcomes (Hawkley and Cacioppo, 2010). Also, social support is reduced 
among those who are not in a relationship (Joutsenniemi et al., 2006). It 
seems that having a partner is of particular importance to mental health, 
beyond the role of increased social capital that a relationship entails. 
 
We found that social capital, and specifically its trust axis, was protective 
against new-onset depressive disorders. Among people with baseline 
depression, low participation and low trust were associated with having more 
depressive symptoms at follow-up in the weighted-only analyses. 
 
The questions measuring trust dealt with feeling safe in the neighbourhood; 
cynical mistrust; and feeling disappointed or surprised by the behaviour of 
people close to you. The construct of “trust” as a component of social capital 
is closely related to personality features and the way an individual interprets 
the neighbourhood and the people surrounding them. The features that allow 
an individual to express trust in relation to their surroundings could also 
make them more resilient to the life stressors that increase the risk of 
depression. Interestingly, one study found no association between social 
capital and incidence of depression, when controlling for personality features 
(Noteboom et al., 2015). In addition to personal characteristics, however, the 
concept of cynical mistrust also reflects the surrounding social environment 
(Nieminen et al., 2008), and an environment of little trust between people 
could thus predispose to depression. Another longitudinal study has also 
shown that both cynical hostility and cynical mistrust were strong risk factors 
for later depressive symptoms (Nabi et al., 2010b). 
 
Low participation showed an association with new-onset depression that 
disappeared when confounders were controlled for. Of note is the lack of 
association between support and both incidence and persistence of 
depression. This highlights the importance of individual characteristics and 
actions over passively received support.  
6.2.5 CHRONIC SOMATIC CONDITIONS  
 
We found a higher incidence of dysthymia among persons with chronic 
somatic conditions at baseline. Somatic comorbidity was not associated with 
persistence with depressive disorders. 
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Having one or two chronic diseases increased the risk of new-onset 
dysthymia, but not MDD. In other studies, chronic physical diseases have 
been associated with incidence of depression (Kaplan et al., 1987, Patten, 
2001, Stegenga et al., 2013, Wang et al., 2010a) and longer course of illness 
(Patten, 2005, Patten et al., 2010). The Canadian NPHS, which is the largest 
study to document association between chronic physical diseases and 
depression, used an instrument that does not differentiate between types of 
depression, and therefore it is not possible to assess whether it was the risk of 
MDD or dysthymia that was increased.  
 
The mechanism by which chronic physical diseases increase the risk of 
dysthymia could be a common underlying factor or causal pathway such as 
inflammation (Kiecolt-Glaser et al., 2015). Or it could be related to the 
experience of living with a chronic illness and its consequences, such as loss 
of the ability to work or the loss of functional capacity. Finally, detection of 
depression among people with chronic somatic conditions may be 
particularly challenging (Menear et al., 2015), and it is possible that 
undetected depressive symptoms become chronic in this population. Most 
likely, the higher risk of depression in this population is a combination of 
these and other factors. 
6.2.6 OTHER PSYCHIATRIC DISORDERS AND PSYCHOLOGICAL 
SYMPTOMS 
 
We found significantly higher incidence of MDD among people with anxiety 
disorders. Psychiatric comorbidity was not associated with persistence of 
depressive disorders, although this has been commonly found in other 
studies (Kessler et al., 2008, Rhebergen et al., 2011). Baseline depressive 
symptoms were predictive of later onset of depressive disorders among 
people with no depression at baseline. Among people with baseline 
depression, severity of depressive symptoms was a strong predictor of all 
negative outcomes: persistence of disorder, level of depressive symptoms at 
follow-up and mortality. 
 
Similar to our findings, previous studies have found higher incidence of 
MDD among people with anxiety disorders (Eaton et al., 2008c, Kessler et 
al., 2008, Klein et al., 2013, Stegenga et al., 2013). Developmentally, the 
genetic etiology in anxiety and depressive symptoms seems to be 
independent in childhood, but shared from adolescence onwards, with an 
overarching internalising genetic factor (Waszczuk et al., 2014). In addition 
to common genetic risk factors, there can be other common underlying risk 
factors, such as childhood adversity, personality features, negative life 
experiences, or the direct impact of the anxiety disorder as a stressor, as well 
Discussion 
90 
as its consequences, such as social isolation (Kessler et al., 2008, Moreno-
Peral et al., 2014, Moscati et al., 2015). Remarkably, alcohol use disorders 
did not increase the risk of depressive disorders in this study. A meta-
analysis found a twofold risk of MDD among people with alcohol use 
disorder (Boden and Fergusson, 2011). 
 
The fact that subclinical depressive symptoms predicted later onset of 
depression is to be expected, and is frequently found in other studies (Ernst 
et al., 1992, Horwath et al., 1992, Klein et al., 2013, Skapinakis et al., 2006). 
These could have been an indicator of a depressive episode about to begin 
already close to baseline, or they may reflect a way of expressing emotions, or 
a personality trait. 
 
It is intuitive that the severity of the disorder also predicted persistence, and 
this is line with previous findings (Lamers et al., 2016, Penninx et al., 2011). 
However, it is notable that depressed people with more depressive symptoms 
at baseline also had higher mortality. This may reflect a particular subtype of 
depression with higher mortality risk (Ziegelstein, 2015), or simply that the 
mechanisms leading to excess mortality in depression are more pronounced 
in more severe disorders. A previous study found increased mortality risk 
already present in persons with mild depressive symptoms, and an increase 
in mortality risk with more severe symptoms (White et al., 2015). 
 
6.3 INCREASING PREVALENCE OF DEPRESSIVE 
DISORDERS AND IMPACT OF NON-PARTICIPATION 
The annual prevalence of depressive disorders in the Finnish population 
increased from 7.3% in 2000 to 9.6% in 2011. The increase was more notable 
in women than men, and in MDD than in dysthymia. Unfortunately, no 
direct explanation for the increase can be derived from this study. However, 
based on the established risk factors for depression, some speculations can 
be made. In 2000, Finland was experiencing steady economic growth, 
whereas in 2011, there was an economic recession. Economic crisis is 
associated with negative mental health impacts such as depression and 
increase in suicide rates (Stuckler et al., 2009, Wahlbeck and McDaid, 2012). 
The impact is mediated via increased unemployment and poverty, individual 
financial difficulties, alcohol-related harm, social exclusion and family strain 
(Wahlbeck and McDaid, 2012). It is possible that the economic downturn 
contributed to the increase in prevalence of depressive disorders in Finland. 
 
Considering that childhood adversities predict onset of depressive disorders, 
some explanation to increasing rates of depression can also be found in the 
previous recession of the early 1990s, when many families experienced 
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unemployment and financial difficulties as well as other adverse 
consequences, such as parental alcohol use. In 2011, people who lived their 
childhood during the recession of the early 1990s were in their early 30s, and 
thus part of the Health 2011 sample. There is abundant evidence of the 
psychological malaise of the generation born in 1987 (Paananen et al., 2013a, 
Paananen et al., 2013b), and it is likely that the negative impact of the 1990s 
recession extends beyond this cohort. 
 
In keeping with our finding of increasing prevalence, during the same 
observation period, 2001-2011, the prevalence of self-reported depression 
increased among all adolescents, and doubled among adolescents whose 
parents were unemployed (Torikka et al., 2014). This further highlights the 
role of family social adversity as a contributor to the increasing prevalence of 
depression. 
 
We found significantly higher prevalence rates of depressive disorders when 
accounting for non-participation by multiple imputation than by inverse 
probability weights only. Based on this, it is evident that non-participation of 
people with mental disorders in health surveys introduces a downward bias 
in all population survey based prevalence estimates that do not correct for 
non-participation (Haapea et al., 2008). This should be taken into account 
when analysing and comparing studies on prevalence of mental disorders. 
Based on our results, multiple imputation seems to be a more effective way of 
correcting for non-participation than the more traditional weighting. 
6.4 MORTALITY IN DEPRESSIVE, ANXIETY AND 
ALCOHOL USE DISORDERS 
We found excess mortality in all studied categories of mental disorders: 
unadjusted, the hazard ratio was 2.4 for depressive; 2.3 for anxiety; and 2.6 
for alcohol use disorders. When adjusted, however, the risk was twofold in 
depressive disorders, and 1.7-fold in alcohol use disorders, but no longer 
significant (HR 1.2) in anxiety disorders. Both anxiety and alcohol use 
disorders had a high rate of unnatural deaths. Among depressed people, 
older individuals, men, and people with more depressive symptoms had 
higher mortality.  
 
Our results regarding excess mortality in depressive disorders are in line with 
recent reviews and meta-analyses that found 1.5 to 1.9-fold mortality risks 
(Baxter et al., 2011, Cuijpers et al., 2014a, Ferrari et al., 2013a, Walker et al., 
2015). The mortality risk was increased despite extensive controlling for 
confounders and long follow-up, factors that had been associated with 
smaller risk in previous studies, and in a general population sample as 
opposed to a clinical one, which also have higher mortality rates (Cuijpers et 
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al., 2014a). Of note, our sample included only people with unipolar 
depression. Most other studies and none of the recent four reviews mention 
explicitly whether only unipolar depression was considered. It seems, 
however, that this would not significantly impact the results, as mortality in 
bipolar disorder is similar to depressive disorders (Walker et al., 2015; Hayes 
et al., 2015).  
 
Based on our results, the approximately twofold risk reported by the meta-
analyses does not appear to be exaggerated or inflated by low-quality studies. 
This supports the saying that there truly is no health without mental health 
(Prince et al., 2007). 
  
A recent meta-analysis found a higher mortality risk among depressed men 
(HR 2.0) than among women (HR 1.6) (Cuijpers et al., 2014b). We had 
similar results in Sub-study III, where depressed men had a higher mortality 
risk than did women. However, in Sub-study IV, there was little difference in 
mortality risk between men and women in the magnitude of the risk. The 
only exception was alcohol use disorders, where the risk was 1.5-fold for men 
and 3.5-fold for women, although due to the small number of observations, 
neither was statistically significant. 
 
Unfortunately, there was not enough data to draw conclusions on the excess 
mortality in specific disorders, and thus the mortality risk in dysthymia 
remains unknown. 
 
Mortality risk in anxiety disorders (HR 1.2) was smaller in magnitude than 
reported in a recent meta-analysis (HR 1.4) (Walker et al., 2015) and not 
significant. Separated by gender, the risk was larger in men than in women, 
as in an earlier study in the Netherlands (van Hout et al., 2004), but not 
significant in either sex. The mortality risk became non-significant when 
controlled for comorbid depressive and alcohol use disorders. It is possible 
that not all studies examining mortality in anxiety disorders have been able 
to control for comorbid depressive disorders, which may have biased the 
results. 
 
Excess mortality in alcohol use disorders was similar to that found in earlier 
studies (Eaton et al., 2008a, Harris and Barraclough, 1998), and similar to 
the twofold risk found in a meta-analysis of general population studies 
(Roerecke and Rehm, 2013), but lower than the 3.5-fold risk in the most 
recent meta-analysis (Laramée et al., 2015). However, most of the studies in 
the meta-analysis simply compared age and gender-controlled mortality 
rates without further adjustments. The fact that we controlled carefully for 
many physical, mental and behavioural risk factors might explain our lower 
risk estimate. Also, mortality was lower in studies where cases were selected 
from the general population and not from treatment centres, and those with 
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longer follow-up, both findings in line with our lower risk estimate. The 
mortality risk was higher in women than in men, which is also consistent 
with earlier studies (John et al., 2013, Roerecke and Rehm, 2013). 
6.5 METHODOLOGICAL CONSIDERATIONS – 
STRENGTHS AND LIMITATIONS 
6.5.1 POPULATION SURVEY DATA 
 
This was a longitudinal population-based study, which has several benefits 
over other study settings. First, as opposed to studies based on clinical 
samples or treatment-based registers, a population-based study includes 
both subjects who have sought treatment and those who have not. Therefore, 
conclusions regarding depressive disorders can be made without the bias 
related to differing help-seeking behaviours (Susukida et al., 2015). Second, 
unlike cross-sectional studies, we were able to draw conclusions on temporal 
associations between potential risk factors and depressive disorders, and also 
describe outcomes of the disorders. Third, as this was a general health 
survey, we had extensive information on the subjects’ physical health status. 
 
However, the longitudinal population setting also posed some limitations. 
Even though the study sample was large, the number of people diagnosed 
with depression at baseline or follow-up was not sufficient to carry out many 
analyses by subgroups, such as gender, age group or type of depression. 
Likewise, when analysing many potential risk factors simultaneously, the 
statistical power was reduced, resulting in widening confidence intervals.  
 
The fact that the survey covered a broad range of health indicators limited 
the time available for questions regarding mental health. As a result, we did 
not have information on, for example, lifetime disorders, and therefore could 
not exclude certain conditions, such as bipolar disorder at follow-up. Also, we 
did not have information on the participants’ mental health between the 
baseline and follow-up interview, which could have been acquired using a 
more detailed mental health interview or more detailed register data. The 
question regarding childhood adversities could have been influenced by 
recall bias. Due to the limited time available for both the mental health 
interview and mental health instruments, we did not include instruments to 
measure personality features, which are important risk factors of depression. 
Finally, we were not able to analyse specific symptoms or clusters of 
symptoms, and whether they had specific risk factors, which has been found 
in other studies (Fried et al., 2014). 
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6.5.2 THE CIDI INTERVIEW 
 
The Composite International Diagnostic Interview, Munich version (M-CIDI) 
(Wittchen and Pfister, 1997) was used to diagnose depressive, anxiety and 
alcohol use disorders in the study. It is one of the most widely used 
structured interviews in population surveys worldwide, including the WHO 
World Mental Health Survey (Kessler and Ustun, 2004), and provides 
excellent opportunities for cross-country comparison. The Munich version of 
the CIDI has good test-retest reliability (Wittchen et al., 1998), and, when 
compared with clinician diagnoses in a treatment setting, has excellent 
sensitivity and specificity (95-100 and 93-100, respectively) (Reed et al., 
1998). 
 
However, in a community sample, where disorders are less common than in 
a clinical setting, the CIDI performs only moderately well. Two studies have 
compared CIDI to the SCID, which is the gold standard of psychometric 
instruments: the NCS-R and the WMHS. In these studies, the CIDI managed 
to capture only 55-69% of persons with depression (sensitivity), and 95-97% 
of the persons without depression (specificity). In the studied populations, 
this led to rather low precision (positive predictive value), 50-55% (Haro et 
al., 2006, Kessler et al., 2003). 
 
Nevertheless, at the population-level, the CIDI neither inflates nor deflates 
the annual prevalence of mental disorders, when compared with the SCID 
(Haro et al., 2006). Therefore, our prevalence estimate can be considered an 
accurate estimate of the prevalence of depressive disorders, as defined in the 
diagnostic manuals. However, it is possible that some subjects identified as 
“cases” of depressive disorders by the CIDI in this study would not have been 
identified as such by a more detailed or semi-structured interview. The 
opposite is also true: the CIDI may have missed some cases. It is difficult to 
assess what, if any, impact this would have had on our results on risk factors 
and prognosis. 
6.5.3 NON-PARTICIPATION AND MULTIPLE IMPUTATION 
 
Selective non-participation complicated the analyses in Sub-studies I-III. 
Previous studies have shown that psychiatric disorders are associated with 
non-participation (de Graaf et al., 2000, Eaton et al., 1992, Haapea et al., 
2008, Suvisaari et al., 2009). Therefore, the fact that the participation rate in 
the mental health interview was only 57%, poses a challenge to the analysis 
and interpretation of the results. 
 
The method chosen to account for non-participation was multiple imputation 
(MI), which is considered superior to other methods of handling missing 
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data (Li et al., 2015, Mackinnon, 2010). Register data, which was available 
for all participants, was used in the imputation. The variables included in the 
imputation model were chosen based on their correlation with both 
missingness and with the outcomes, depressive disorders. Sensitivity 
analyses were carried out with varying numbers of imputed data sets. The 
results based on MI are thus considered more reliable and are reported as 
primary results. In the case of Sub-studies II-III, there was little difference 
between the weighted-only and imputed results. In Sub-study I, however, the 
prevalence was very different, which is understandable given the increased 
non-participation among people with hospitalisations for depression or other 
mental disorders. For this reason, the results cannot be considered as reliable 
as results based on a sample with a higher participation rate. Also, there was 
considerable imprecision in the point estimates based on results where 
imputation had a larger impact, such as prevalence among the older age 
groups.  
 
Finally, the register data used in the imputation only included people with 
hospitalisations for mental disorders, and was not able to capture people in 
outpatient treatment, or those without treatment. Also, lifetime instead of 
past year treatments were utilised in the imputation. It is difficult to assess 
the impact of these limitations of the register data on the imputed results. 
However, the fact that any register data was available for imputation can be 
considered an advantage over other, less complete sources of information for 
imputation. 
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7 CONCLUSIONS 
This study contributed to the existing body of literature documenting the 
large burden of depressive disorders. It showed that depressive disorders are 
common in the Finnish population and that their prevalence has increased 
over the past decade; that certain negative experiences and individual 
characteristics place people at a higher risk of developing these disorders; 
that depressive disorders often have a chronic course and negative 
consequences on the individual’s life and health; and that people with 
depressive and alcohol use disorders have a higher mortality risk than the 
general population. 
 
The findings of this study are in line with earlier literature and bring clarity 
to some issues where controversial findings existed. The impact of non-
participation on prevalence estimates should be taken into account in health 
surveys, and also in estimates of burden of mental disorders. Unlike previous 
studies from earlier decades, we found an increasing prevalence of depressive 
disorders. Further studies should examine whether this is a global 
phenomenon or specific to Finland. 
 
In terms of reducing the burden of depressive disorders, it is crucial to focus 
efforts on prevention. Several types of psychological interventions, both 
targeted and universal, are effective in preventing incidence of depression 
(van Zoonen et al., 2014). Based on this study, people with subclinical 
depressive symptoms, anxiety disorders, low trust and multiple childhood 
adversities are at a particularly high risk of developing depression and could 
be suitable target groups for preventive interventions. In addition, welfare 
policies should target families with children to minimise the impact of 
parental illness, unemployment, financial difficulties and other adversities on 
children (Wahlbeck and McDaid, 2012). Specific policies to reduce bullying 
could be effective in reducing incidence of depression (Scott et al., 2014). 
 
We found no evidence of low socioeconomic position being a risk factor for 
depression, but dysthymia was more prevalent among those with low or 
intermediate education. There was no evidence to support the causation 
theory, where low socioeconomic position causes depression. Since 
dysthymia was more prevalent among those with low education, and 
previously low income has been associated with current depressive disorders 
in the same survey, selection seems more likely than causation to explain the 
link between depressive disorders and low SEP in the Finnish context. 
Therefore, policy efforts should aim at protecting persons with persistent 
depression from downward social mobility or failure to achieve desired 
educational and income level. These efforts could include reduction of stigma 
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and discrimination in educational institutions and work places, and 
improving early access to treatment (Muntaner et al., 2004). Stigma related 
to depression is still very common, with 41% of people with MDD in high-
income countries reporting being “shunned” or avoided by others, and 23% 
reporting discrimination in regard to their physical health problems 
(Lasalvia et al., 2015). 
 
As opposed to new-onset depression, we found few predictors of persistence 
of depression. However, in clinical treatment settings, it is important to 
recognise that severity of the disorder is an important predictor of the 
longitudinal course, perhaps more so than comorbidity or other individual 
characteristics. The fact that unmarried people are more likely to have a 
persistent course of illness means that they warrant special attention in 
treatment settings. Research efforts could be directed toward finding better 
ways to distinguish those at a higher risk of adverse outcomes. Recently, a 
more densely connected network of symptoms was found to predict 
longitudinal course of depression in a network analysis using Bayesian 
methods (van Borkulo et al., 2015). Different prediction algorithms have 
been developed to predict risk of recurrence in depressed people (van Loo et 
al., 2015a, Wang et al., 2014), where a wide variety of risk factors, including 
demographic characteristics, level of depressive and anxiety symptoms, 
psychiatric and family history, physical health and life events, contribute to 
the risk of recurrence. 
 
Beyond the diagnostic status and remission, we found broad and long-term 
adverse outcomes in subclinical symptoms, health-related quality of life and 
self-rated health. All of these were more pronounced in individuals with 
dysthymia, even after recovery from the disorder was achieved. Since the 
negative health impacts of depressive disorders persist more than a decade 
after the initial diagnosis, a history of depressive disorder should be regarded 
as a sign of increased health needs in the health care system, and a system of 
periodical general health check-ups could be considered even after formal 
recovery. Also self-care and monitoring in the recovery period could be 
encouraged, and different online and other tools developed for this purpose. 
 
As did numerous other studies, we found increased mortality among people 
with depressive and alcohol use disorders, and the risk was increased despite 
long follow-up and extensive controlling for confounders. Little doubt 
remains over the excess mortality in mental disorders. In fact, as Graham 
Thornicroft writes: “It has been clear for more than 50 years that people with 
the more disabling forms of mental illness do not live as long as those 
without mental illness. -- What are the implications of these sobering 
findings? Three things are clear. Firstly, the time for descriptive research 
alone is over. We now need evidence-based interventions that can reduce 
excess mortality. -- Thirdly, this huge loss of life among people with mental 
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illness needs to be recognised as a human rights disgrace.” (Thornicroft, 
2013) In the same spirit, Suetani comments: “Scarce research money would 
be better invested in assessing how to implement proven interventions and in 
developing better treatments and prevention strategies.” (Suetani et al., 
2015). These interventions to reduce excess mortality include adequate 
treatment of depression, both antidepressants and psychological treatment 
(Cuijpers and Schoevers, 2004). The physical health needs of persons with 
mental disorders and the inequities in access to health care also need to be 
adequately addressed (Lawrence and Kisely, 2010). 
 
Based on this study, recommendations for further research include: 
 
1. Assess recent trends of prevalence of depressive disorders in other 
settings besides Finland; 
2. Identify reasons for the increasing prevalence of depressive 
disorders, particularly in women; 
3. Examine ways to improve participation of people with mental 
disorders in population studies and the statistical methods to 
account for their non-participation; 
4. Identify better predictors of different negative outcomes of 
depressive disorders that can be used in the clinical practice; 
5. Assess implementation and effectiveness of interventions to reduce 
excess mortality in mental disorders.  
 
Some policy recommendations based on this study are: 
1. Target preventive programmes to people with subclinical 
depressive symptoms, anxiety disorders, low trust, and childhood 
adversities; 
2. Sustain implementation of welfare policies that target families with 
children to minimise the impact of parental illness, unemployment, 
financial difficulties and other adversities, in order to prevent onset 
of depressive disorders in these children. Implement policies to 
reduce bullying and assess their impact on reducing incidence of 
depression; 
3. Protect individuals with depression from downward social 
movement, or failure to achieve desired educational level, via 
reduction of stigma and discrimination in educational institutions 
and work places, facilitating return to work after sick leave, and 
improving early access to treatment; 
4. Offer special support to unmarried or lonely depressed individuals, 
either at the treatment facilities or the non-governmental sector; 
5. Implement policies to tackle the vast inequity in mortality between 
people with mental disorders and those without. Address the 
physical health needs of people with mental disorders, both during 
the symptomatic phase and after formal recovery.  
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